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91. ABSTRACT
Patient-controlled analgesia (PCA) has been used
for the past 30 years as an alternative method to
administer postoperative analgesia. PCA allows
patients to self-administer small boluses of opioids,
providing better dose titration and regulation. The
quantity of analgesic available to the patient is
limited by the prescribed PCA variables; demand
dose size, lockout period and hourly or 4-hourly
limits. The aim of the present series of studies was
to examine which analgesic: oxycodone, morphine
or tramadol, would be the best alternative in PCA
after orthopaedic, maxillofacial or plastic surgery.
In addition, a comparison was made of epidural
bupivacaine-fentanyl infusion along with i.v. PCA,
and along with patient-controlled epidural analgesia
(PCEA).
A total of 274 patients were assigned to receive
opioids by either i.v. patient-controlled analgesia
(220 patients), epidural infusion (64) or patient-
controlled epidural analgesia (27). In patients
undergoing a plastic reconstruction of the breast or
a major operation on the vertebral column, the
hypothesis was tested that the efficacy of oxycodone
differs from that of morphine in postoperative pain
treatment with i.v. PCA. In a prospective, double-
blind, randomized study, tramadol was compared
with oxycodone in PCA after maxillofacial surgery.
Sixty women scheduled to undergo microvascular
breast reconstruction under standard general
anaesthesia were enrolled in a study on the
performance of i.v. PCA with tramadol or
morphine, and drug- and technique-related side-
effects were compared. The efficacy, safety, side-
effects, and patient satisfaction of epidural
bupivacaine-fentanyl analgesia and intravenous PCA
with morphine were compared after elective anterior
cruciate ligament reconstruction of the knee. The
efficacy of bupivacaine-fentanyl PCEA and
continuous epidural infusion with the same mixture
for treatment of pain after total knee arthroplasty
were compared.
Analgesia was similar with oxycodone, morphine
or tramadol in PCA. There appears to be no clear
advantage to using one opioid over the others, with
each producing a similar incidence of side-effects,
except that tramadol was associated with a
disturbingly high incidence of nausea and vomiting.
To diminish the nausea and vomiting associated
with PCA, it is recommended to add a prophylactic
antiemetic to i.v. opioid PCA.
PCEA compared with continuous bupivacaine-
fentanyl epidural infusion provided equal analgesia
but was associated with a dose-sparing effect of 40%.
PCA and PCEA were shown to achieve high
patient satisfaction, but despite this, a significant
number of patients experienced troublesome side-
effects, especially nausea and vomiting. The
incidence of serious complications such as
respiratory depression with hypoxaemia or
pneumonia was low both with i.v. PCA with three
different analgesics and with PCEA.
Abstract
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2. INTRODUCTION
Despite constantly increasing understanding of
pain mechanisms and improved technology in
pain therapy for the anaesthetist, the provision
of adequate postoperative pain relief is still a
challenge. Unfortunately, postoperative pain
relief, which is conventionally provided by
parenteral medication, is often incomplete
(Keeri-Szanto and Heaman 1972; Tammisto
1978; Tammisto and Tigerstedt 1982; Ready
1999).  As far as we know, conventional
prescription of opioids—to be given by nurses
‘as required’—seldom produces an adequate level
of analgesia. In addition, it is impossible to
accurately predict what analgesic dosage will be
required to provide sufficient pain relief or how
much pain a patient will experience after an
operation. Adequate pain control may even
improve recovery from surgery by reducing stress
and improving pulmonary function (Craig 1981;
Bonica 1987; Kehlet 1989, 1994; Scott and
Kehlet 1988). Optimal postoperative analgesia
may also reduce postoperative complications and
shorten postoperative recovery (Kehlet 1994; de
Leon-Casasola et al. 1994).
Patient-controlled analgesia (PCA) has become
an established technique for the treatment of
postoperative pain (Sechzer 1968; Scott 1970; Keeri-
Szanto 1971; Tammisto 1978; Ready 1990;
Zimmermann and Stewart 1993; Lehmann 1995).
It has been shown to offer a number of advantages,
including good analgesia, avoidance of fluctuations
in analgesia, lower total analgesic dosage, and
improved patient satisfaction. This method allows
self-administration of small, frequent doses of
analgesics to maintain a state of constant pain
control.
The effectiveness and safety of PCA with a
number of opioids have already been demonstrated
(Lehmann 1995; Ready 2000); however, the
optimal opioid has not yet been found. The typical
side-effects of opioids, such as nausea and vomiting,
sedation, respiratory depression, and pruritus may
sometimes hamper the successful application of
PCA (Nottcutt and Morgan 1990; Lehmann 1993;
Baxter 1994). On the other hand, oxycodone,
which is the most commonly used parenteral opioid
for postoperative pain in Finland (Pöyhiä 1994),
has not yet been studied for its efficacy in PCA.
The concept of patient-controlled epidural
analgesia (PCEA) is derived from PCA, and PCEA
has been successfully used for obstetric analgesia
(Gambling et al. 1988; Viscomi and Eisenach 1991;
Parker et al. 1992b; Parker and White 1992). PCEA
may also be suitable for postoperative analgesia after
orthopaedic operations (Liu et al. 1998). As with
PCA, it allows the patient to be in control of the
dosing and timing of analgesia.
The purpose of the present study was to evaluate
the potency, efficacy, and side-effects of three
analgesics, e.g., oxycodone, morphine, and
tramadol, in PCA and to compare continuous
epidural infusion, i.v. PCA, and PCEA in
postoperative analgesia. Patient satisfaction with i.v.
PCA and PCEA, and the safety of these methods
in postoperative pain management were also
investigated.
Introduction
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3. REVIEW OF THE LITERATURE
3.1. PATIENT-CONTROLLED
ANALGESIA (PCA)
3.1.1. Principles and development of
PCA
Traditional techniques for the provision of
postoperative analgesia by intermittent i.v. or i.m.
injections of an opioid drug do not meet the needs
of every patient. Patient-controlled analgesia (PCA)
allows patients to self-administer small boluses of
opioids, providing better dose titration and
regulation (Bennett et al. 1982b). This avoids the
‘peak and valley’ effects encountered with
conventional i.m. administration of analgesics.
Stable drug plasma concentration is an important
goal of postoperative pain management. When
using PCA, the plasma concentration at which the
patient becomes sufficiently uncomfortable to
make a dose demand has become known as the
minimum effective (analgesic) concentration
(ME(A)C) (Dahlström et al. 1982; Gourlay et al.
1988; Lehmann 1995; Woodhouse and Mather
2000). Intrapatient variation in MEC for morphine
in the treatment of postoperative pain has been
relatively small (Dahlström et al. 1982), but
interindividual variation in the plasma concentration
of opioid required to achieve adequate pain relief
has been large (Dahlström et al. 1982; Gourlay et
al. 1988). As a result, self-administration of opioids
after abdominal and orthopaedic surgery has been
characterized by considerable variability in individual
morphine consumption (Lehmann et al. 1985).
An important advantage of PCA is its ability to
minimize the time-delay between perception of pain
and administration of medication (Lutz and Lamer
1990).
The first attempts to establish i.v. PCA were
made in the late 1960s, after PCA with intermittent
i.v. doses of narcotic analgesics was first described
by Philip Sechzer (Sechzer 1968, 1971, 1990), who
reported that such a patient-controlled analgesic-
demand system for the alleviation of pain and for
the reliable measurement of pain and pain relief had
been under study since 1965. In this system, patients
when they felt pain during recovery from surgery
were instructed to press a button. When this button
was pressed, a nurse observer administered 1 ml of
a pethidine- or morphine-containing solution
(Sechzer 1968, 1971). At the same time, the
concept of PCA was developed independently in
the U.K. by Scott, who permitted the patients to
operate a hinge-lever spring clamp that restrained
the i.v. drip flow of pethidine, so patients controlled
their own i.v. infusion rate of analgesic (Scott 1970).
In 1970, Forrest and his co-workers described a
more sophisticated apparatus (Demand
Dropmaster), which, after the patient pressed the
button on a handgrip device, automatically
dispensed i.v. analgesic drugs on demand (Forrest
et al. 1970). Keeri-Szanto eventually developed a
commercial machine with an electrically controlled
syringe pump (Keeri-Szanto 1971). The analgesic
efficacy of PCA has been demonstrated to be
superior to that obtained with intermittent i.m.
injections (Keeri-Szanto and Heaman 1972). After
this, several experimental systems for the self-
administration of analgesics have been described
(Evans et al. 1976; Tammisto 1978; Hull et al. 1979;
Hull and Sibbald 1981; Rosenberg et al. 1984).
Tammisto developed a Finnish PCA apparatus with
a special but simple technique for improving the
safety of the pain management (Tammisto 1978).
When the development of microprocessors
improved the technology of PCA pumps, the
clinical use of PCA became more popular and
widespread (Kay 1981; Rowbotham 1992a).
PCA is an effective and safe means to provide
pain relief for cancer patients (Citron et al. 1986),
and the technique has been proven beneficial in
Review of the literature
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patients ranging in age from children as young as 5
years to frail, elderly men (Egbert et al. 1990; Irwin
et al. 1992).
In patients undergoing bone marrow
transplantation and in women after abdominal
hysterectomy, PCA therapy decreases the morphine
requirement compared to that in a continuous
morphine infusion (Hill et al. 1990; Parker et al.
1991).
The continuous background infusion of
morphine during PCA analgesia has been studied
extensively, and shown to increase morphine
consumption, sedation, and respiratory depression
without improving pain relief or patient satisfaction
(Owen et al. 1989b; Wu and Purcell 1990; Parker
et al. 1991, 1992a; Tigerstedt et al. 1991; Russell et
al. 1993; Baxter 1994; Etches 1994). On the other
hand, following abdominal surgery, a continuous
morphine infusion of 1 mg/h with i.v. PCA
(morphine 1 mg bolus and 5 min lockout period)
has improved analgesia during the first 24 hours.
This method was associated with a greater incidence
of complications than with i.v. PCA alone (Dawson
et al. 1995). In the light of all this, the efficacy of
combining a continuous infusion with i.v. PCA is
uncertain.
Patient-controlled analgesic administration offers
the best individualization, and in addition, PCA
should be considered for those patients with the
most resistant pain (Tammisto 1978; Tammisto and
Tigerstedt 1982).
3.1.2. PCA versus i.m. opioids
Several reports indicate that PCA is superior to i.m.
supplementation of the same opioid (Bennett et
al. 1982a; Bollish et al. 1985; Hecker and Albert
1988; Wasylak et al. 1990; Wheatley et al. 1992;
Boulanger et al. 1993; Thomas et al. 1995).
However, other studies could demonstrate no
difference between the pain ratings of the PCA and
i.m. groups (Ellis et al. 1982; Dahl et al. 1987;
Albert and Talbott 1988; Ferrante et al. 1988;
Kleiman et al. 1988; McGrath et al. 1989). No
statistical difference existed between the two groups
in the quantity of morphine used in the
postoperative period in three of these studies (Dahl
et al. 1987; Ferrante et al. 1988; Kleiman et al.
1988).
3.1.3. PCA versus epidural analgesics
Several studies have shown superior pain relief with
epidural analgesia than with systemic opioids
(Hjortsø et al. 1985; Loper et al. 1989; Weller et al.
1991; Cade et al. 1992; Benzon et al. 1993; Eriksson-
Mjöberg et al. 1997; Boylan et al. 1998; Singelyn et
al. 1998). These studies have included very different
regimens. Both morphine and lipophilic opioids
epidurally have usually been compared with i.v.
PCA morphine for postoperative pain relief after
various operations.
Epidural morphine provided greater pain relief
at rest and upon coughing than did i.v. PCA
morphine after cholecystectomy (Loper et al.
1989) and after anterior cruciate ligament repair
(Loper and Ready 1989). After total hip or total
knee arthroplasty, patients receiving continuous
epidural morphine recalled having less pain
between observations than did those receiving i.v.
PCA morphine (Weller et al. 1991). Similarly,
after total knee arthroplasty, continuous epidural
analgesia with 0.125% bupivacaine with
sufentanil 0.1 µg/ml and clonidine 1 µg/ml at
the rate of 10 ml/h provided better pain relief
and faster postoperative knee rehabilitation than
did i.v. PCA with morphine (Singelyn et al.
1998). A thoracic epidural fentanyl infusion was
significantly better than i.v. PCA morphine in
providing pain relief after thoracotomy (Benzon
et al. 1993).
Continuous i.v. infusions of lipophilic opioids
(fentanyl, alfentanil) and an epidural technique
have been found to be equally effective (Ellis et
al. 1990; Loper et al. 1990; Camu and Debucquoy
1991). When compared with continuous i.v.
fentanyl, continuous epidural fentanyl infusion
offers no clinical advantages for the management
of postoperative pain after caesarean section (Ellis
et al. 1990) or after repair of the anterior cruciate
ligament of the knee (Loper et al. 1990), and the
side-effect profile between the two routes of
Review of the literature
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administration was similar in both these two
studies. I.v. and epidural infusions of alfentanil
after abdominal hysterectomy were equally
effective for providing pain relief, and the incidence
of opioid-related side-effects was similar (Camu
and Debucquoy 1991). Glass and colleagues,
comparing i.v. PCA with fentanyl to epidurally
administered fentanyl, showed that onset of
adequate analgesia was slower via the epidural
route, but no significant difference in analgesia
between the two routes of administration resulted
(Glass et al. 1992). Nor, after 60 minutes, did
plasma fentanyl concentrations differ. These
findings thus reflect the high lipophilicity of
fentanyl, which rapidly diffuses out of the epidural
space causing a systemic effect.
When epidural opioids were compared to i.v.
PCA after caesarean section, patients who had i.v.
PCA reported greater satisfaction; PCA was an
attractive alternative (Eisenach et al. 1988; Harrison
et al. 1988). After another study involving
caesarean section, PCA with combined continuous
infusion and demand dosing of pethidine was
superior to continuous infusion of epidural
morphine (Smith et al. 1991).
3.1.4. Choice of analgesic
The most popular opioid in PCA has been
morphine (White 1988; Stanley et al. 1996), but
also most other opioids have been tested (Lehmann
1995). Ideally, the analgesic for PCA should have a
rapid onset of analgesic action, be highly efficacious
in relieving pain, have an intermediate duration of
action (30-60 min), produce no tolerance or
dependence, and have no or minimal side-effects
or adverse drug interactions (White 1988; Etches
1999).
3.1.4.1. Morphine
Pharmacokinetics and pharmacodynamics
of morphine
Opioids are capable of producing analgesia over a
wide range of doses (Inturrisi 1984). As the dose is
increased, analgesia improves linearly, virtually to
the point of loss of consciousness (Inturrisi 1984).
Dahlström and co-workers (1982) discovered that
the measured plasma concentrations of morphine
which resulted in subjectively satisfactory analgesia
were 21 ± 12 ng/ml. On the other hand, Graves
and colleagues (1985) defined a minimum effective
plasma morphine concentration of 20-40 ng/ml.
The maximum plasma morphine concentration was
82 ng/ml (Graves et al. 1985). Morphine is
considered to be the standard opioid to which all
other opioids are compared.
Morphine is metabolized primarily in the liver
by conjugation to form water-soluble morphine-
3- and morphine-6-glucuronides, which are
morphine’s main metabolites. The 3-glucuronide
is devoid of analgesic activity and has poor affinity
to opioid receptors (Pasternak et al. 1987). The
other important metabolite of morphine, the 6-
glucuronide (Osborne et al. 1990; Portenoy et al.
1992), has been found to be twice as potent as
morphine when either is given s.c. in mice (Paul et
al. 1989), but when morphine-6-glucuronide was
injected either intracerebroventricularly or
intrathecally in mice, it was approximately 90 and
650 times, respectively, more potent as an analgesic
than morphine (Paul et al. 1989). In rats,
morphine-6-glucuronide microinjected into the
periaqueductal gray matter had 20-fold greater
potency than did morphine (Pasternak et al. 1987).
Similarly, in healthy volunteers, when electrical and
cold pain tests were used, a single bolus dose of
morphine-6-glucuronide 5 mg i.v. had significant
analgesia on a visual analogue scale (Buetler et al.
2000). In addition, morphine-6-glucuronide had
high affinity to µ-receptors, but not to δ- or κ-
receptors (Pasternak et al. 1987). The kidneys
excrete both these metabolites, and patients with
renal disease are at risk for prolonged effects
(Osborne et al. 1986, 1993).
Postoperative pain relief with morphine
In the relief of postoperative pain after elective
cholecystectomy, continuous infusion of morphine
was inferior to the traditional intermittent i.m.
bolus administration technique (Marshall et al.
1985). This could be attributed to the apparent
rapid development of tolerance in patients who
Review of the literature
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received the infusion; in addition, continuous
infusion of morphine failed to reduce the dose of
morphine required.
After abdominal operations, the routine use of a
continuous morphine infusion in combination with
the standard PCA regimen did not improve pain
management when compared with PCA alone
(Owen et al. 1989b; Wu and Purcell 1990; Parker
et al. 1991, 1992a; Russell et al. 1993; Baxter 1994;
Etches 1994). The pattern of hourly morphine
consumption has been found to follow a diurnal
rhythm, with peak times of demand at 9.00 and
20.00 hours (Burns et al. 1989).
Relatively healthy patients undergoing elective
hysterectomy have experienced little difference
between pethidine and morphine with respect to
analgesia, to nausea and vomiting, to sedation and
satisfaction when using i.v. PCA with either
morphine (bolus dose 2 mg, lockout time 10 min)
or pethidine (bolus dose 20 mg, lockout time 10
min) (Stanley et al. 1996). The morphine:
pethidine potency ratio was in this study 1:9.4.
After major knee surgery, i.v. PCA with
morphine was less effective at rest and during
continuous passive motion than was analgesia
provided by continuous epidural infusion with a
combination of 1% lidocaine, 0.03 mg/ml
morphine, and 2 µg/ml clonidine administered at
0.1 ml/kg/h, but side-effects such as urinary
retention, dysesthesia, and arterial hypotension were
encountered more frequently in the continuous
epidural infusion group (Capdevila et al. 1999).
After elective cholecystectomy, i.v. PCA with
morphine did not cause more nausea and vomiting
than the conventional i.m. method (Robinson and
Fell 1991). Morphine is the opioid most commonly
used for PCA (Etches 1999). Typically given as a 1-
mg to 2-mg bolus in adults, analgesia is rapid in
onset and of intermediate duration (Etches 1999).
3.1.4.2. Oxycodone
Pharmacokinetics and pharmacodynamics
of oxycodone
Oxycodone (6-deoxy-7,8-dehydro-14-hydroxy-3-
O-methyl-6-oxomorphine or 14-hydroxy-7,8-
dihydrocodeinone) is a semisynthetic opioid
prepared from a naturally occurring opium alkaloid,
thebaine.
Back in 1959, Brittain suggested that oxycodone
had a potency similar to that of morphine. In a
nonrandomized clinical trial of 600 patients treated
with i.m. oxycodone for postoperative pain, he
evaluated oxycodone 10 mg as being as effective as
morphine 10 mg or pethidine 100 mg (Brittain
1959). Similarly, after abdominal surgery, 0.1 mg/
kg of oxycodone i.v. has been shown to be as
effective as 1 mg/kg of pethidine i.v. in postoperative
pain relief (Takki and Tammisto 1973).
Likewise, Morrison and co-workers (1971)
confirmed that oxycodone 10 mg, pentazocine 20
mg, and a combination of morphine 10 mg and
cyclizine 50 mg (Cyclimorph®) showed nearly the
same analgesic effectiveness, although not better
than the standard pethidine dose of 100 mg.
On the other hand, in the immediate
postoperative period after major abdominal surgery,
the equianalgesic dose ratio of i.v. oxycodone and
morphine has shown a ratio of 2:3 (oxycodone had
analgesic potency 1.5 times that of morphine)
(Kalso et al. 1991), whereas in cancer pain,
oxycodone has shown, with systemic
administration, an analgesic potency 0.7 times that
of morphine (Kalso and Vainio 1990; Kalso et al.
1990). Moreover, as early as 1978, Beaver and co-
workers showed that for cancer pain i.m. oxycodone
is less potent than morphine (Beaver et al. 1978).
In practice, the typical i.m. and i.v. doses of
oxycodone used by Finnish anaesthetists have been
close to those of morphine (Pöyhiä 1994).
However, for acute postoperative pain after major
abdominal surgery, the equianalgesic dose ratio of
epidurally administered oxycodone to morphine has
been shown to be 8:1 (Bäcklund et al. 1997). The
reason for this great difference in dose ratio may be
that the µ-receptor affinity of oxycodone is clearly
lower (Kalso et al. 1990; Ross and Smith 1997).
The other reason may be that part of the analgesic
potency of oxycodone in man is attributable to the
action of its metabolites (Kalso et al. 1990).
Noroxycodone (Weinstein and Gaylord 1979)
and oxymorphone (Baselt and Stewart 1978) are
the two major metabolites of oxycodone in man.
Review of the literature
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Metabolism of oxycodone in animals and in man
occurs mainly in the liver, and proceeds by N-
demethylation (noroxycodone), O-demethylation
(oxymorphone), 6-ketoreduction, and conjugation
with glucuronic acid (Ishida et al. 1982; Pöyhiä et
al. 1992b; Otton et al. 1993). In vitro studies
indicate that O-methylation of oxycodone to
oxymorphone is catalyzed by cytochrome P450
2D6 (CYP2D6) in the liver (Otton et al. 1993).
Of these two metabolites, only oxymorphone
has been shown to have clinically significant opioid
agonist activity in humans; it is a µ-opioid receptor
agonist with a relative potency estimated as
approximately 14 times that of oxycodone when
both drugs are administered parenterally (Beaver et
al. 1978). However, in healthy adults, plasma
concentration of this metabolite after i.v., i.m., or
oral administration of oxycodone has been
negligible (Pöyhiä et al. 1991, 1992b; Kaiko et al.
1996). In contrast, although the analgesic potency
of noroxycodone, which has only weak affinity for
µ-opioid receptors (Chen et al. 1991), has not been
established in humans, in animal studies it is a
considerably weaker analgesic than is either
oxycodone or morphine (Weinstein and Gaylord
1979; Leow and Smith 1994). Probably,
oxycodone itself is primarily responsible for the
analgesic effect after oral oxycodone administration
(Kaiko et al. 1996). Recent investigations have
shown that the antinociceptive effects of oxycodone
are mediated by CNS κ-opioid receptors, in contrast
to morphine, which interacts primarily with µ-
opioid receptors (Ross and Smith 1997; Black and
Trevethick 1998).
Elimination of oxycodone has been shown to
be impaired both in end-stage liver cirrhosis and in
uremic patients, and the excretion of its metabolites
in uremic patients is severely impaired (Kirvelä et
al. 1996; Tallgren et al. 1997).
Although the adverse effects of oxycodone are
quite similar to those of morphine (Kalso and Vainio
1990; Kalso et al. 1991), morphine seemed to cause
more sedation than did oxycodone (Kalso et al.
1991). On the other hand, some evidence exists
that oxycodone might cause slightly more profound
respiratory depression than morphine (Mildh et al.
2000). In patients with pain following
cholecystectomy, degree of sedation with pethidine
and oxycodone was similar (Takki and Tammisto
1973).
Pöyhiä and colleagues (1992a) have discovered
that after oral oxycodone, no histamine liberation
could be detected in either plasma or urine. On the
contrary, morphine and pethidine have been found
to liberate histamine from mast cells (Rosow et al.
1982; Flacke et al. 1987).
Postoperative pain relief with oxycodone
Oxycodone has been in clinical use since 1917, and
in Finland is the most commonly used parenteral
opioid for severe acute postoperative pain (Pöyhiä
1994). Oxycodone by 1990 was also a popular drug
for PCA in Finland (Pöyhiä 1994). Due to its high
bioavailability (60%) (Pöyhiä et al. 1992b), it has
been successfully and widely used also for the
management of chronic pain and terminal cancer
pain (Inturrisi 1984; Leow et al. 1995; Heiskanen
and Kalso 1997; Bruera et al. 1998).
In patients undergoing endoscopic anterior
cruciate ligament reconstruction using a patellar
tendon autograft, i.m. ketorolac supplemented by
oral oxycodone provided comparable analgesia with
fewer side-effects than i.v. PCA with morphine
(Popp et al. 1998).
For pain control after craniotomy, i.v. PCA with
oxycodone supplemented with either ketoprofen
or paracetamol was a suitable method; the small
doses of oxycodone (0.03 mg/kg) used were found
to cause no respiratory depression or excessive
sedation (Tanskanen et al. 1999).
3.1.4.3. Tramadol
Pharmacokinetics and pharmacodynamics
of tramadol
Tramadol is a weak centrally acting analgesic drug
with a low affinity for µ-opioid receptors (Lehmann
1994; Eggers and Power 1995; Duthie 1998; Budd
and Langford 1999). In addition, it also inhibits
the neuronal reuptake of  noradrenaline and 5-
hydroxytryptamine (5-HT) (Raffa et al. 1992;
Driessen et al. 1993), and it facilitates 5-HT release
(Driessen and Reimann 1992; Bamigbade et al.
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1997). Clinical studies have confirmed that the
analgesic effect of tramadol is apportioned between
its opioid and monoaminergic components
(Desmeules et al. 1996). Tramadol is a racemic
mixture: each enantiomer has different opioid-
binding affinity and they also differ in their
inhibition of monoaminergic re-uptake, with the
(+)enantiomer inhibiting predominantly 5-HT
uptake, and the (-)enantiomer inhibiting
noradrenaline uptake (Raffa et al. 1993).
Tramadol is metabolized in the liver by the
cytochrome P450 enzyme system (CYP2D6) to
form at least 11 metabolites, of which O-
desmethyltramadol predominates and has a higher
affinity than tramadol for opioid receptors (Sevcik
et al. 1993; Poulsen et al. 1996).
Although the potency ratio between tramadol
and pethidine has been calculated to be 0.94 (Vickers
et al. 1992), tramadol 0.6 mg/kg was shown to
cause no respiratory depression, as did an equipotent
dose of pethidine (Tarkkila et al. 1998). Likewise,
an equianalgesic dose of tramadol has much less
effect on the respiratory centre than morphine
(Vickers et al. 1992).
Postoperative pain relief with tramadol
Tramadol is minimally sedative and does not cause
constipation, but in parenteral use is associated with
more nausea and vomiting than either morphine
or codeine (Hopkins et al. 1998; Ng et al. 1998).
Moreover, when used in PCA for postoperative pain
treatment, tramadol causes nausea and vomiting
relatively often (Stamer et al. 1997).
In a large, multi-centre, double-blind, controlled
trial, in which the analgesic efficacy of tramadol
was compared to that of morphine given in repeated
i.v. boluses as required to control postoperative pain
following abdominal surgery over 24 hours,
tramadol was less sedative than morphine (Vickers
and Paravicini 1995).
In PCA after colorectal or head and neck surgery,
a mixture of tramadol and droperidol is associated
with reduced incidence and severity of nausea and
vomiting, when compared with tramadol alone (Ng
et al. 1997). The quality of analgesia and degree of
sedation between the two groups were similar.
Investigations of tramadol have shown that
doubling the demand dose in PCA results in
significantly higher efficacy without doubling the
total consumption of analgesic (Lehmann et al.
1986).
Tramadol is useful in the treatment of mild to
moderate acute or chronic pain, as well as in
postoperative and obstetric pain and in pain of other
origins including neuralgia, arthritis, and post-
traumatic pain (Lee et al. 1993).
3.1.5. Bolus dose
The size of the demand dose is of great importance
for successful PCA. The correct demand dose for
most of the opioids used is unknown. The optimal
dose of morphine to start with could be anything
from 0.5 to 4 mg (Bennett 1986; Rosen 1986;
Lehmann 1993; Etches 1999; Ready 2000). The
optimal demand dose may be defined as the
minimum dose to produce appreciable analgesia
consistently without causing either subjective or
objective side-effects (Owen et al. 1989a). In a
comparison of i.v. morphine of 0.5, 1.0, and 2.0
mg bolus dose sizes, Owen and colleagues (1989a)
found 1.0 mg to be closest to optimal.
Unfortunately, one size of demand dose does not
suit all patients.
A variable bolus dose of morphine in i.v. PCA
provided adequate postoperative analgesia (Love et
al. 1996). In that study, patients could choose a
bolus dose of either 0.5, 1.0, or 1.5 mg morphine
by pressing a small, medium, or large button, on a
handpiece. This system offered no advantage over
conventional analgesia, because no difference
occurred in the ease of controlling pain, in the
satisfaction with pain control, in the experience of
pain on movement, in the quality of sleep, in the
severity of nausea, or in the incidence of vomiting
between the variable dose PCA and conventional
PCA (Love et al. 1996). If the bolus dose is too
large, patients may become drowsy after each dose
and not request additional boluses until they
awaken.
When the demand dose of tramadol was 18.5
mg, only 5% of patients had unsatisfactory pain
relief, but with a smaller demand dose of 9.6 mg
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tramadol, 38% patients reported unsatisfactory pain
scores (Lehmann et al. 1986).
3.1.6. Lockout time
The minimum allowable period between PCA
bolus doses is the lockout time, which must be
pharmacokinetically appropriate for the opioid
used. If adequate analgesia is not achieved, the
lockout time should be shortened or the bolus dose
increased. The purpose of the lockout period is to
make sure that most of the effect of a bolus dose
has been experienced before a further dose can be
obtained.
Only a few investigations define optimum
lockout periods (Smythe et al. 1993; Badner et al.
1996). Smythe and co-workers found no significant
differences in the efficacy or toxicity of three i.v.
morphine PCA regimens. The three morphine
regimens were: 1 mg with a 6 min lockout, 2 mg
with a 12 min lockout and 2 mg with a 20 min
lockout. Similarly, when a small dose of morphine
(1 mg) and a short lockout period (6 min) in PCA
has been compared to larger doses and longer
lockout periods, no difference in analgesia and side-
effects appeared between the groups (Badner et al.
1996). Lockout times in the range 5 to 20 minutes
should be appropriate in most cases (Lehmann
1993; Etches 1999; Ready 2000).
Evidence from an investigation with fentanyl
supports the opinion that patients do make
demands at essentially consistent blood
concentrations (MEAC). However, these diminish
with time, probably as the pain stimulus decreases
(Gourlay et al. 1988).
It is important to make sure that no delays occur
in drug transport into the patient’s circulation.
Therefore, a three-way stopcock should be
connected directly to the i.v. cannula to ensure a
minimum lockout period.
3.1.7. Hourly or 4-hourly limits
The safety of postoperative PCA management is
confirmed by setting hourly or 4-hourly total dose
limits for the PCA pump. Whether the inclusion
of these limits is of any benefit to patients has not
been convincingly shown because few patients reach
these limits. On the other hand, the sedative and
respiratory effects of PCA opioids seem to appear
in most patients at doses far less than the dose limits
prescribed (Etches 1999).
In fact, accurate scientific data for setting the
variables of i.v. PCA analgesia, drug choice,
incremental dose, lockout interval, and maximum
dose have been lacking (Mather and Owen 1988).
3.1.8. Duration of administration
In most studies, PCA is administered for 24 to 48
hours. On the other hand, some retrospective
studies disclose that i.v. PCA therapy has been
utilized for an average of 68 hours (range 8-144)
(Wermeling et al. 1987, 1992). The consumption
of i.v. PCA morphine during 72 postoperatively
hours was retrospectively analyzed in the audit of
1,233 Chinese patients (Tsui et al. 1996). It is
difficult to decide exactly when i.v. PCA therapy
should be changed to oral analgesics (Owen et al.
1988). On the other hand, PCA therapy is
sometimes discontinued because of significant side-
effects or because at the patient’s request.
3.2. RISKS AND SIDE-EFFECTS OF
PCA
In addition to analgesic efficacy, choice of analgesic
therapy should be based on the incidence and nature
of side-effects, as well as on the patient’s preference
for the method. PCA with an opioid is associated
with the usual opioid-related side-effects, such as
nausea and vomiting, urinary retention, and pruritus,
as well as the most feared one, i.e., respiratory
depression. In meta-analysis of 15 randomized
control trials, patients using PCA obtained better
pain relief than those receiving conventional i.m.
analgesia, without an increase in adverse effects
(Ballantyne et al. 1993). This benefit is, however,
only weakly supported by meta-analysis, because
only 3 of 15 studies provided data on patient
satisfaction, and these three studies together
included only 216 patients (Ballantyne et al. 1993).
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This kind of systematic analysis may also provide
important information about side-effects and
problems of PCA (Brown 1993).
3.2.1. Nausea and vomiting
For patients using i.v. PCA, reported frequencies
of nausea and vomiting vary between 10% and
88% (Table 1). In the systematic review by Tramèr
and Walder (1999), the incidence of nausea and
vomiting after various kinds of operations in
patients receiving no prophylactic antiemetic
treatment added to their PCA morphine was
approximately 50%.
Three different doses, 0.5, 1, and 2 mg, of
morphine administered via PCA, caused no
difference in the incidence of nausea, vomiting, or
administration of antiemetics (Owen et al. 1989a).
The incidence of nausea and vomiting associated
with the increased dose of i.v. PCA tramadol was
higher than with i.v. PCA morphine (Ng et al.
1998; Pang et al. 1999) and resulted in a decrease
in patient satisfaction (Pang et al.1999).
No differences appeared the occurrence of side-
effects such as nausea and vomiting between PCA
and i.m. dosing of opioids (Tamsen et al. 1979;
Dahl et al. 1987; Kleiman et al. 1988). However,
nausea was significantly less frequent in the regular
i.m. morphine group than with fentanyl
administered by i.v. PCA, the reason for which may
be that two different opioids were being compared
(Welchew 1983).
After cholecystectomy, for patients receiving
epidural morphine or i.v. PCA morphine no
significant difference existed with respect to
incidence of nausea (Loper et al. 1989). Similar
results were reported after anterior cruciate ligament
repair (Loper and Ready 1989). On the other hand,
after lower abdominal surgery, nausea was reported
more frequently by patients using i.v. diamorphine
PCA than by those with continuous epidural
infusion of 0.15% bupivacaine with 0.01%
diamorphine (Madej et al. 1992). A possible
explanation for more nausea in the i.v. group in
this study could be the increased opioid
consumption in the PCA group (Madej et al.
1992).
Postoperative nausea and vomiting (PONV) are
frequently caused by opioids, although the aetiology
of PONV is multifactorial. Women are more likely
to experience nausea and vomiting (Wheatley et al.
1991; Cohen et al. 1994; Larsson and Lundberg
1995; Myles et al. 1997), and those undergoing
Table 1. Incidence (%) of postoperative nausea and vomiting (PONV) with i.v. PCA.
Analgesic No. of pat. Surgery Nausea Vomiting Reference
Morphine 40 Abdominal, orthopaedic 10* Lehmann et al. 1985
Morphine 15 Abdominal 27 27 Robinson and Fell 1991
Morphine 30 Gynaecologic 88* Semple et al. 1992
Morphine 27 Gynaecologic 56 11 Williams et al. 1993
Morphine 1 233 Miscellaneous 35 18 Tsui et al. 1996
Morphine 50 Laparoscopic 16 32 Naguib et al. 1998
Morphine 40 Orthopaedic 28 5 Pang et al. 1999
Oxycodone 45 Neurosurgical 18 NR Tanskanen et al. 1999
Tramadol 60 Abdominal, orthopaedic 20* Lehmann et al. 1986
Tramadol 50 Laparoscopic 18 32 Naguib et al. 1998
Tramadol 40 Orthopaedic 48 28 Pang et al. 1999
*nausea and vomiting together, NR = not reported
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gynaecological operations, breast surgery or middle
ear surgery seem to have the highest incidence of
PONV (Wheatley et al. 1991; Cohen et al. 1994;
Honkavaara et al. 1994; Larsson and Lundberg
1995).
In general, opioid premedication has been more
frequently associated with postoperative nausea and
vomiting than are benzodiazepines (Larsson and
Lundberg 1995).
3.2.2. Urinary retention
The use of i.v. morphine or pethidine
hydrochloride PCA after elective open
cholecystectomy has been associated with greater
urinary retention than was the case for i.m.
morphine or pethidine hydrochloride (Petros et al.
1992). Similarly, urinary retention after open
appendicectomy was 13 times as likely to occur in
patients who had i.v. morphine or pethidine
hydrochloride PCA as in those with i.m. analgesic
administration of morphine or pethidine
hydrochloride (Petros et al. 1993). It should be
noted that in that study the increased amount of
analgesic agent given postoperatively was related to
urinary retention. Patients who used PCA after
abdominal or vaginal hysterectomy were 5.7 times
as likely to have urinary retention as those given an
i.m. agent, but the amount and type of analgesic
agent given postoperatively had little influence on
the risk of retention (Petros et al. 1994). These
studies by Petros and co-workers included no report
of measurement of analgesia, but none of these
studies showed any significant difference between
total doses of analgesics. The morphine:pethidine
potency ratio in these studies was considered to be
1:8.
After cholecystectomy there was no significant
difference with respect to the incidence of urinary
retention between epidural morphine and i.v. PCA
morphine (Loper et al. 1989). On the other hand,
patients receiving epidural morphine after anterior
cruciate ligament repair had a significantly higher
incidence of moderate urinary retention than did
patients receiving i.v. PCA with morphine (Loper
and Ready 1989).
3.2.3. Pruritus
Opioid analgesics, regardless of the route of
administration, can produce troublesome pruritus.
The incidence of pruritus varies greatly. Only 5%
of patients receiving i.v. PCA morphine after
caesarean section experienced treatable pruritus
(Eisenach et al. 1988); 28% of patients using i.v.
PCA with morphine after thoracotomy had pruritus
(Benzon et al. 1993).
Some authors have found no significant
difference in incidence of pruritus in patients
receiving either epidural or i.v. PCA opioids (Loper
and Ready 1989; Wheatley et al. 1990; Madej et
al. 1992). On the other hand, there are also studies
showing opioid epidural analgesia to cause more
frequent pruritus than does i.v. PCA with an opioid
(Eisenach et al. 1988; Harrison et al. 1988; Loper et
al. 1989; Smith et al. 1991; Weller et al. 1991). In
these studies, 27% to 85% of patients receiving
epidural morphine complained of bothersome
pruritus, whereas the incidence of pruritus in i.v.
PCA varied from none to 60% (Eisenach et al.
1988; Harrison et al. 1988; Loper et al. 1989; Smith
et al. 1991; Weller et al. 1991).
3.2.4. Respiratory depression
Fortunately, respiratory depression and hypoxaemia
are quite rare postoperative complications with
adequate opioid administration and supervision
(Ready et al. 1988; Etches 1994). Usually, patients
who titrate their own analgesics do not
overmedicate themselves, and PCA doses as high
as 108 mg/hour morphine have safely been
administered (Wermeling et al. 1986). Naturally,
excessive self-administration of i.v. PCA opioid may
result in respiratory depression. In healthy volunteers
this respiratory depression was clearly indicated by
elevated levels of end-tidal CO
2
-levels 3 to 4.5 hours
after the administration of i.m. oxycodone (0.13
mg/kg) (Saarialho-Kere et al. 1989). Morphine-
and oxycodone-induced respiratory depression was
characterized by changes in breathing pattern,
including a decrease in minute ventilation and in
respiratory rate and a later increase in tidal volume
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(Leino et al. 1999). Likewise, when postoperative
patients used i.v. morphine PCA, substantial
nocturnal hypoxaemia caused by hypoventilation
could be measured with continuous pulse oximetry;
oxygenation could be improved by providing
supplemental oxygen (Stone et al. 1999). In healthy
male volunteers given oxycodone and morphine in
a random, cross-over, double-blind fashion,
oxycodone caused a more profound respiratory
depression, indicated by diminished alveolar
ventilation and decreased arterial oxygen tension
(Mildh et al. 2000). Pain itself stimulates breathing,
so that risk for respiratory depression may be greater
in volunteer studies without pain stimulation than
with postoperative patients. On the other hand,
opioid therapy can improve ventilation by
diminishing pain during deep breathing and
coughing (Lange et al. 1988; George et al. 1994).
An equianalgesic dose of tramadol has much less
effect on the respiratory centre than does morphine
(Vickers et al. 1992). In fact, tramadol causes little
or no respiratory depression (Paravicini et al. 1982).
Tarkkila with his colleagues found the respiratory
effects of tramadol to be similar to those of placebo
in spontaneously breathing anaesthetized patients,
and equianalgesic doses of oxycodone or pethidine
caused significant respiratory depression compared
with that from tramadol (Tarkkila et al. 1997,
1998).
During the first year of the Acute Pain Service in
the York District General Hospital (U.K.) four of
the 510 patients (0.8%) receiving i.v. PCA with
morphine had oversedation with airway obstruction
that required treatment with i.v. naloxone, three of
whom had respiratory depression associated with a
ventilatory frequency less than 10 breaths per
minute (Wheatley et al. 1991). Etches (1994)
reported an incidence of severe respiratory depression
associated with PCA of 0.5%. This finding is in
agreement with two other reports (Macintyre et al.
1990; Fleming and Coombs 1992). In a Canadian
survey, the incidence of severe respiratory depression
with the use of PCA was as low as 0.03%
(Zimmermann and Stewart 1993). In an audit of
1,233 Chinese patients using i.v. morphine PCA,
bradypnoea and oxygen desaturation were reported
in 0.5% and 1.6%, respectively (Tsui et al. 1996).
Factors increasing the potential for respiratory
depression can be divided into ‘patient related’ and
‘technique related’ (Baxter 1994). The main causes
of patient related factors include advanced age,
respiratory failure, hypovolaemia, and concurrent
use of other sedative medication (Ready et al. 1988;
Baxter 1994). The technique related factors include
use of a continuous infusion, operator error, and
equipment failure (Baxter 1994).
The use of background infusion with PCA may
be associated with a higher incidence of severe
respiratory depression than for PCA alone (Notgutt
and Morgan 1990; Schug and Torrie 1993), because
continuous opioid infusion lacks the inherent safety
of patient feedback provided by PCA. On the other
hand, Doyle and co-workers (1993a) found that
inclusion of a background infusion of morphine 4
µg/kg/h in a PCA regimen for children did not
increase the incidence of side-effects and was
associated with less hypoxaemia and a better sleep
pattern than without any background infusion. In
another study by the same group, a background
infusion of morphine 20 µg/kg/h produced a
significant increase in morphine consumption
without improving analgesia, and there was a
significant increase in the incidence of opioid-
induced side-effects such as respiratory depression,
sedation, and nausea or vomiting (Doyle et al.
1993b).
Operator errors resulted in severe overdosing of
patients, with the attendant risk of clinically
significant respiratory depression and apnoea (White
1987). Unfortunately, errors in programming are
quite easy to make, because of the design of many
electronic PCA devices. Erroneous excessively large
bolus doses of opioids to elderly or hypovolaemic
patients have been important contributing factors
in respiratory complications (White 1987). The
most serious event occurred when a PCA pump
began to administer boluses independently of the
patient trigger (Notgutt and Morgan 1990).
Similarly, profound respiratory depression and
oversedation occurred during malfunction of the
PCA pump in four other cases (Thomas and Owen
1988; Christie et al. 1990; Notcutt et al. 1992).
Respiratory depression was not observed in
neurosurgical patients receiving 1-mg bolus doses
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of morphine with PCA (Stoneham et al. 1996).
The study by Tanskanen and her colleagues (1999)
evaluating the feasibility and safety of PCA with
oxycodone in neurosurgical patients revealed no
evidence of respiratory depression or excessive
sedation, presumably because the i.v. bolus dose of
oxycodone in this study was only 0.03 mg/kg. The
potential for overdosing patients may thus be
minimized if small bolus doses are used with an
adequate lockout period between successive doses.
A study in which continuous pulse oximetry was
used after lower abdominal surgery suggested that
i.v. PCA with diamorphine was less likely to cause
hypoxaemia than was epidural infusion of
diamorphine (Wheatley et al. 1990). Another study
concluded that patients receiving opioids by any
route after caesarean section were potentially at risk
for respiratory depression (Brose and Cohen 1989).
However, there occurred a higher incidence of brief
periods of severe desaturation following continuous
epidural morphine or i.m. pethidine, but only
prolonged periods of mild desaturation following
i.v. PCA with pethidine (Brose and Cohen 1989).
3.2.5. Sedation
Sedation can occur with all opioids and is dose-
related (Inturrisi 1984). Postoperative opioid use
and side-effects are often influenced by the patient’s
age. After abdominal hysterectomy, patients over
70 had a higher incidence of excessive sedation and
confusion than did patients under 40, despite
receiving less analgesic medication with a
continuous infusion of morphine by the standard
PCA method or with PCA alone (Parker et al.
1991). It has been reported that for postoperative
pain after caesarean sections, i.v. PCA with pethidine
provided less sedation and more immediate pain
relief than did i.m. pethidine injection (Rayburn et
al. 1988).
3.3. PATIENT SATISFACTION
WITH PCA
In general, patient satisfaction with PCA has been
high (Tamsen et al. 1982; Ferrante et al. 1988;
Smith et al. 1991). Retrospective data from 1,233
Chinese patients who utilized i.v. morphine PCA
showed that 77% were satisfied with the use of
PCA and with their pain relief (Tsui et al. 1996).
Ferrante and co-workers (1988) also had patients
rating PCA as superior to i.m. opioid
administration with regard to pain relief.
Patient satisfaction with postoperative analgesic
care is a complex issue; several factors other than
analgesia, such as surgery, incidence of side-effects,
and patient-care in the perioperative period may play
a role in patients’ assessment of the success of
postoperative pain management. The most
common reason for dissatisfaction has been
inadequate pain relief (Tsui et al. 1996).
A meta-analysis by Ballantyne and colleagues
(1993) showed PCA to be associated with a small
improvement in pain relief, but with an increase in
patient satisfaction. Patients who can control their
own level of pain through self-medication by using
PCA may choose to use less of the drug and accept
higher pain levels rather than experience more
adverse effects. Eisenach and co-workers (1988)
showed that after caesarean section, i.v. PCA with
morphine produced better pain relief and
satisfaction than i.m. morphine, although both
groups tolerated some pain and used only a small
portion of the maximum prescribed narcotic. In
that study, decreased pain scores correlated with
patient satisfaction within the entire study
population, but the relationship differed among
groups (Eisenach et al. 1988); for example, among
women who reported the highest satisfaction, pain
scores were significantly higher in the PCA group
than in the epidural morphine group. A adequacy
of pain relief, feeling safe, and a lack of side-effects
seem to be predictors of patients’ feeling ‘extremely
positive’ about PCA (Chumbley et al. 1999).
In a prospective study of a total of 916 patients,
of whom 711 received i.v. morphine PCA and 205
received epidural morphine analgesia following a
wide variety of gynaecological, urological,
orthopaedic, and general surgical procedures, overall
satisfaction was high (Egan and Ready 1994).
However, in that study, the major disadvantage for
the PCA group was the lack of effective analgesia
in the recovery room immediately following
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surgery and before PCA was instituted, and for the
epidural group unpleasant side-effects.
3.4. SAFETY OF PCA
The most important problems in safety of PCA
are operator and technical errors, which may lead
to overdosing and significant complications (White
1987; Grey and Sweeney 1988; Grover and Heath
1992).
Before loss of consciousness occurs, undesirable
effects such as notable sedation, mental clouding,
nausea and vomiting, and/or respiratory depression
occur, which may impose a practical limit on the
use of PCA, in order to ensure the safety (Inturrisi
1984).
3.5. PATIENT ACCEPTANCE AND
ABILITY TO USE PCA
In a prospective study of 230 adult women after
abdominal hysterectomy, only 2% of the patients
had difficulty in using the PCA device (Parker et
al. 1991). On the other hand, 15 to 20% of 60
patients recovering from balanced general anaesthesia
after elective abdominal or orthopaedic surgery had
irremediable difficulties in handling equipment
known as the On-Demand Analgesia Computer
(ODAC) used for the i.v. self-administration of
tramadol: some elderly patients in particular were
unable to perform the task of pressing the button
twice within one second (Lehmann et al. 1986).
3.6. PATIENT-CONTROLLED
EPIDURAL ANALGESIA (PCEA)
3.6.1. PCEA in obstetric pain
PCEA for labour analgesia was introduced by
Gambling and co-workers (1988), and several
studies demonstrating the efficacy of PCEA in
labour have shown this technique to offer an
alternative method for continuous epidural analgesia
(Gambling et al. 1988, 1993; Viscomi and Eisenach
1991). PCEA with hydromorphone has also
appeared to be a suitable alternative to conventional
i.v. PCA after caesarean section and has offered the
advantages of less opioid medication and a more
rapid recovery (Parker and White 1992).
Purdie and colleagues (1992) compared three
techniques used to provide epidural analgesia during
the first stage of labour: 1) 0.25% plain bupivacaine
10 ml with top-ups on patient demand delivered
by the midwife, 2) continuous infusion of 0.125%
plain bupivacaine 10 ml/h, and 3) PCEA delivering
3 ml boluses of 0.25% bupivacaine. Each technique
produced comparable analgesia, and achieved
equivalent maternal satisfaction with no difference
between mode of obstetric delivery, and no
complications (Purdie et al. 1992). However, careful
monitoring of the upper level of the epidural block
was required, because in seven of 75 mothers in the
PCEA group, the block height was above T7
(Purdie et al. 1992).
PCEA with hydromorphone has also been
shown to be a safe and effective method of
providing pain relief after elective caesarean
delivery with epidural bupivacaine, although the
addition of 0.08% bupivacaine or a basal infusion
of hydromorphone, or both, increased side-effects
without improving the patients’ pain relief (Parker
et al. 1992b). One double-blind study, which was
designed to determine the best dose variables for
PCEA and to compare PCEA with continuous
infusion epidural analgesia during the first stage
of labour, revealed that PCEA was a safe and
effective alternative to continuous epidural
infusion, irrespective of the initial dose variables
selected (Gambling et al. 1993). In that study, five
groups of parturients self-administered 0.125%
bupivacaine with 1:400 000 adrenaline and
fentanyl 2.5 µg/ml using PCA pumps supplying
2 to 6 ml bolus doses at 10- to 30-minute lockout
times.
A continuous background infusion has been
shown not to be essential to achieve good analgesia
with PCEA for labour and delivery, but a trend
has appeared towards an increased necessity for
physician-administered supplemental bupivacaine
in the use of pure PCEA without background
infusion (Ferrante et al. 1994).
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High patient satisfaction has been reported
among parturients using PCEA (Gambling et al.
1990, 1993; Paech 1991; Viscomi and Eisenach
1991; Purdie et al. 1992). It has been discovered
that PCEA in obstetric analgesic practice is at least
as effective as the continuous epidural infusion
system in producing analgesia and has the advantages
of increased satisfaction and of reduction in the
local anaesthetic required (Curry et al. 1994). A
prospective, randomized study of PCEA and
midwife-administered intermittent bolus epidural
analgesia with 0.125% bupivacaine plus fentanyl
has been reported to produce the same median
hourly pain scores, similar ratings for analgesia, and
similar satisfaction (Paech et al. 1995); maximum
pain scores were higher in those receiving midwife-
administered intermitted bolus epidural analgesia,
and incidence of urinary catheterization was
significantly more common in those using PCEA.
3.6.2. PCEA in postoperative analgesia
There is only a limited history of the use of PCEA
for postoperative pain excluding obstetrics.
However, in recent years, studies have been done
of PCEA after orthopaedic operations or after
thoracotomy. Nolan and co-workers (1992)
demonstrated the effectiveness and safety of
PCEA in 11 patients following post-traumatic
pelvic reconstruction, finding that PCEA did
not significantly reduce analgesic requirements
in comparison to continuous infusion epidural
analgesia. One reason for this was the small size
of
 
the groups. A greater degree of desaturation
after upper abdominal surgery has been
discovered in pat ients  who received a
continuous epidural fentanyl infusion with
nurse-controlled supplements than when
fentanyl administration was patient-controlled
(Owen et al. 1993): PCEA with fentanyl was
more effective and less of the drug was required
than for continuous epidural infusion. In a
comparison of PCEA with morphine and
bupivacaine to PCEA with fentanyl and
bupivacaine, postoperative analgesia after major
abdominal surgery, proved to be excellent in
both groups; but incidence of nausea was less
in the patients receiving fentanyl (10%) with
PCEA than morphine (45%) with PCEA (Özalp
et al. 1998). In that study, pruritus occurred
less often in the fentanyl group (5%) than in
the morphine group (30%).
After total hip arthroplasty, i.v. PCA with
morphine; PCEA with 0.125% bupivacaine,
sufentanil 0.1 µg/ml, and clonidine 1 µg/ml; and
continuous ‘3-in-1’ block, all provided comparable
pain relief (Singelyn and Gouverneur 1999). The
PCEA was programmed to give a continuous
infusion of 0.125% bupivacaine, sufentanil 0.1 µg/
ml and clonidine 1 µg/ml at 5 to 7 ml/h, and the
PCEA bolus of 2.5 ml/30 min. Another study
involving patients after total joint arthroplasty,
demonstrated a significant synergistic effect of a
combination of 0.125% levobupivacaine and 4 µg/
ml fentanyl, compared with either drug alone, when
utilizing PCEA (Kopacz et al. 1999). In a large study
of 1,030 surgical patients, PCEA provided effective
and safe postoperative analgesia on hospital wards
(Liu et al.1998).
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4. AIMS OF THE STUDY
The main purpose of the present study was to investigate and to improve patient-controlled analgesia
(PCA) in postoperative pain management.
The specific aims of the study were:
1. to compare the potency, efficacy, side-effects, and pharmacokinetics of the two opioids morphine and
oxycodone, and the weak opioid µ-receptor agonist tramadol in i.v. PCA, after breast and back surgery,
after maxillofacial surgery, and after microvascular breast reconstruction (I-III).
2. to compare the efficacy, safety, side-effects, and patient satisfaction with i.v. PCA and epidural analgesia
after anterior cruriate ligament reconstruction of the  knee (IV).
3. to compare the efficacy of patient-controlled epidural analgesia (PCEA) with bupivacaine and fentanyl
to that of continuous epidural infusion of bupivacaine and fentanyl for the control pain after knee
arthroplasty (V).
4. to evaluate the safety of and patient satisfaction with i.v. PCA and PCEA (I-V), and to elucidate the
clinical feasibility of PCEA in postoperative management of pain in elderly patients (V).
Aims of the study
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5. PATIENTS AND METHODS
5.1. STUDY PATIENTS
The studies were carried out in the Department of
Anaesthesiology of Töölö Hospital (I-V) and the
Surgical Hospital (II) of Helsinki University Central
Hospital. All studies were prospective, randomized,
and double-blind. The study protocols were
approved by the Ethics Committees of the Helsinki
University Central Hospital. A total of 274 patients
were involved in the five different studies (Table
2), with only ASA I-III patients accepted. In
addition, exclusion criteria included clinical or
laboratory contraindications to epidural catheter
insertion (IV-V), inability to use the PCA device,
or allergy to any of the study medications. Before
entering the study, every patient provided a written
(I, III-V) and/or verbal (I-V) informed consent.
5.2. PREMEDICATION
Oral diazepam 0.15 to 0.2 mg/kg was given as
premedication approximately 60 min before
induction of anaesthesia (I-IV). In Study V,
diazepam 5 to 10 mg, depending on both weight
and age, was given orally as premedication
approximately 1 h before induction of anaesthesia.
5.3. ANAESTHETIC METHODS
5.3.1. General anaesthesia (I-III)
A standardized general anaesthetic technique was
used in Studies I to III. After glycopyrrolate 0.2
mg i.v., anaesthesia was induced with thiopental 4
to 6 mg/kg (I, III) or propofol 2 mg/kg (II) and
together with fentanyl 2 µg/kg (I), 3 µg/kg (III) or
alfentanil 0.5 to 1 mg (II). Tracheal intubation was
facilitated by vecuronium 0.1 mg/kg (I, III) or
atracurium 0.5 mg/kg (I) or suxamethonium 1.5
mg/kg (II). Muscle relaxation was maintained with
intermittent doses of vecuronium (I-III) or
atracurium (I), and the degree of relaxation was
measured by train-of-four monitoring with a
peripheral neurostimulator. Anaesthesia was
maintained with enflurane in 30% oxygen and 70%
nitrous oxide (I) or isoflurane (1-1.5%) in a mixture
of 65 to 70% N
2
O in oxygen (II, III).
Supplemental doses of fentanyl 1 to 2 µg/kg hourly
(I, III) or alfentanil 0.5 mg were given for analgesia
if the systolic arterial pressure rose 20% over the
basic value (II). In Study III, after induction of
anaesthesia a gastric tube was inserted for the
Table 2. Summary of study characteristics.
N Surgery Intervention
Study I 50 reduction mammaplasty / lumbar spinal fusion PCA: oxycodone / morphine
Study II 54 maxillofacial surgery (osteotomies) PCA: tramadol / oxycodone
Study III 60 microvascular breast reconstruction PCA: tramadol / morphine
Study IV 56 ligament reconstruction of a knee PCA* / epidural#
Study V 54 total knee arthroplasty PCEA# / epidural#
Total 274
* morphine,  # bupivacaine and fentanyl
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evacuation of stomach contents. All the women in
Study III had a urinary catheter in place for more
than 24 h. Electrocardiogram, heart rate,
noninvasive arterial pressure (I, II) or invasive arterial
pressure (III), peripheral oxyhaemoglobin saturation,
end-tidal carbon dioxide, and inspiratory oxygen
concentrations were monitored continuously
throughout anaesthesia (I-III). Haematocrit was
maintained at 0.30 to 0.35, and red cell concentrates
were given if necessary (I-III). At the end of the
surgery, residual neuromuscular blockade, measured
by train-of-four monitoring with a peripheral
neurostimulator, was antagonized with 0.4 mg
glycopyrrolate followed by 2 mg of neostigmine
(I-III).
5.3.2. Combined spinal epidural
anaesthesia (IV-V)
The epidural catheter was inserted with a 16- or
18-G Tuohy needle in the L2-L3 interspace with
the patient in the lateral position before surgery.
The midline approach with ‘loss of resistance’
technique was used. The catheter was inserted 3 to
5 cm past the needle tip into the epidural space. An
epidural test dose of 4 ml lidocaine 10 mg/ml with
adrenaline 10 µg/ml was administered through the
catheter to rule out intravascular or intrathecal
position of the catheter. Then a subarachnoid
puncture was performed in the midline at the L3-
L4 interspace with a 27-G needle, and spinal
anaesthesia was induced with 3 ml of plain
bupivacaine 5 mg/ml, 5 min after the epidural test
dose. If the level of anaesthesia after this initial dosage
was below the L1 dermatome or if the patient
complained of pain, supplementary doses, 10 ml
of lidocaine 10 mg/ml with adrenaline, were given
through the inserted epidural catheter. During the
operation, diazepam 2.5 to 5 mg i.v. (IV-V) or
midazolam 1 mg i.v. (V), or small doses of propofol
for sedation (IV-V), and fentanyl 0.05 to 0.1 mg
i.v. (IV-V) for analgesia were given when required.
In the operating room and in the recovery room
noninvasive blood pressure (oscillotonometry),
ECG, heart rate, and SpO
2
 were monitored. No
urinary bladder catheter was used. Intravenous fluids
(Ringer’s acetate, 6% hydroxyethyl starch) and
erythrocyte concentrate transfusions were given on
an individual basis, as required by clinical
judgement. If systolic arterial pressure decreased
below 95 mmHg, ephedrine 5 to 10 mg i.v. was
given. All the patients had a pneumatic tourniquet
around the thigh inflated 300 to 350 mmHg
during the operation. In the recovery room, after
the level of anaesthesia had decreased below L1,
another test dose of 8 ml lidocaine 10 mg/ml with
adrenaline was given through the epidural catheter
to confirm its proper position (V). Low molecular
weight heparin (LMWH), enoxaparin 40 mg
(Klexane®) once a day beginning 12 to 16 h before
anaesthesia, was used for thromboprophylaxis.
5.4. ADJUNCTIVE MEDICATIONS
At the end of anaesthesia, for postoperative
prophylactic analgesia, paracetamol 500 mg rectally
(III) or ketoprofen 100 mg i.v. (IV) was given, and
both types of medication were continued three
times a day. After the operation all the patients in
Study V received paracetamol 1 g orally three times
a day starting in the postanaesthesia care unit. In
Study II, to diminish postoperative oedema, every
patient received dexamethasone 8 mg twice a day,
from the evening before the operation to the first
postoperative day. In addition, in Study II,
diclofenac sodium 1 mg/kg i.m. was given before
incision and at the end of anaesthesia.
5.5. PAIN RELIEF
During the preoperative visit, patients were
instructed in the use of a PCA pump. Immediately
after completion of surgery, the patients were
connected to the pump via an intravenous line with
a one-way (anti-reflux) rotating valve (Vygon®,
Laboratories pharmaceutics, France) (I-IV). The
pump was either a Graseby 3300 PCA pump
(Graseby Medical Ltd, UK) (I, III-V) or Abbott
Pain Management Provider APM (Abbott
Laboratories, North Chicago, IL, USA) (II). No
basal infusion was used (I-IV). In Study V, the
PCEA pump was set to deliver both an infusion
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and a bolus in both the groups to provide blindness
for the study. In Studies II to III, loading of the
analgesic was utilized. The patient, anaesthetist, and
nurses were blinded to the contents of the PCA or
PCEA syringe (I-V). The lockout period of the PCA
pump was 5 min in Studies I to III.
Study I:
Patients were randomly assigned to receive a drug
solution which contained either oxycodone 3 mg/
ml or morphine 4.5 mg/ml by the PCA pump,
which was set to deliver a bolus dose of 30 µg/kg
oxycodone or 45 µg/kg morphine. Patients could
take a maximum of 6 bolus doses per hour.
Study II:
During the immediate recovery period, either i.v.
tramadol 10 mg or oxycodone 1 mg increments
were administered every 2 min until the patient was
pain-free or fell asleep. Then the PCA pump was
connected, and patients were randomly assigned to
receive a drug solution that contained either 6 mg/
ml tramadol or 0.6 mg/ml oxycodone; the bolus
dose was tramadol 300 µg/kg or oxycodone 30 µg/
kg. Maximum dosage per 4 hours was tramadol 4
mg/kg or oxycodone 0.4 mg/kg.
Study III:
When the patient requested pain medication, the
anaesthetist gave the study drug, tramadol 10 mg
or morphine  1 mg i.v., every 2 min until pain
control was judged by the patient to be satisfactory.
After this initial dose, the PCA pump was
connected. The PCA drug solution contained
either tramadol 20 mg/ml or morphine 2 mg/ml.
The PCA pump was set to deliver a bolus dose of
450 µg/kg tramadol or 45 µg/kg morphine.
Patients could take a maximum of six bolus doses
per hour.
Study IV:
Patients were randomly divided into three groups.
Each patient could use an i.v. PCA device with 40
µg/kg bolus doses of morphine with a lockout
period of 10 min and a maximum dose of 240 µg/
kg/h. Patients in the F10 group received a
continuous epidural infusion with bupivacaine 1
mg/ml and fentanyl 10 µg/ml, patients in the F5
group received bupivacaine 1 mg/ml and fentanyl
5 µg/ml, and patients in the S group received saline.
Study V:
In both groups the epidural solution contained 1.1
mg/ml bupivacaine and 5 µg/ml fentanyl. The
PCEA group could demand a bolus of 0.05 ml/kg
of the solution, with a lockout interval of 10 min,
and a total dose limit of three bolus doses per hour.
The EPI group received a continuous infusion of
0.1 ml/kg/h of the same bupivacaine-fentanyl
solution, and only a minimal extra bolus of 0.2 ml
with the same lockout interval. The 10-min lockout
period was chosen to ensure adequate time for the
bolus to work before a further dose was allowed.
Start time, the amount, and the number of PCA
demands and bolus doses with the time
administered were automatically recorded. All other
postoperative medication was recorded from the
drug chart.
5.5.1. Loading dose
In Studies II and III, when the patient requested
pain medication, the anaesthetist gave the study drug
i.v. in a double-blind fashion every 2 min until the
patient was pain-free or fell asleep. The evaluated
drugs and doses were tramadol 10 mg (II, III),
oxycodone 1 mg (II), and morphine 1 mg (III).
The maximum doses of loading were tenfold.
5.5.2. Rescue medication
In Study I, if the patient tried to take over 6 bolus
doses per hour the PCA pump sounded an alarm,
the anaesthetist was called and observed the grade
of sedation and pattern of breathing, and the clamp
of the pump was released for another dose of opioid.
In Studies II to V, the rescue analgesic was
oxycodone 0.1 to 0.15 mg/kg i.m. Droperidol 10
µg/kg i.v. or i.m. was given in the case of prolonged
emesis or vomiting.
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5.6. POSTOPERATIVE FOLLOW-UP
Patients were assessed for pain, side-effects, and
satisfaction at predetermined timepoints, 3 h (I,
IV, V), 9 h (I, IV, V), 20 h (IV, V), and 24 h (I).
In Study II, an interview was done at 2 h after
commencing PCA and on the ward at 21.00
hours, and at 9.00 hours the next morning. In
Study III, a trained nurse interviewed the patients
2 h after PCA had been started, and on the ward
at 20.00 hours, at 8.00 hours the next morning,
at 20.00 hours the next evening, and finally at
8.00 on the second morning after operation. In
Studies I, II and IV, the interviewer was the
anaesthetist, but in Studies III and V, a trained
nurse.
5.6.1. Assessment of postoperative
analgesia
The intensity of pain was evaluated with a 50-
cm visual analogue scale (VAS) (Figure 1)
(Tigerstedt et al. 1988b). A red and white ruler,
50 cm long and 10 cm broad, was employed,
with an increasing red field representing pain
intensity and a centimetre scale on the reverse
side (0=no pain, 50=worst possible pain)
(Tigerstedt et al. 1988b). Use of this ruler was
explained to al l  the patients during the
preoperative visit.
The intensity of pain following surgery was
assessed by the patient himself at rest and during
activity, during arm or leg lifting (I, III-V) or
during mouth opening (II). In Studies II, III and
V, pain was assessed also on a 4-point verbal rating
scale (VRS) (0=no pain, 1=slight pain, 2=moderate
pain, 3=severe pain).
5.6.2. Assessment of the spread of
analgesia, motor block, and sensory
block (IV-V)
Cephalad dermatomal extension of sensory
analgesia was assessed by pinprick, and the
degree of motor block of the lower extremities
was recorded by criteria slightly modified from
those described by Bromage (1965) (0=no motor
block, 1=inability to raise extended legs, 2=inability
to flex knees, 3=inability to flex angle joints) at 3
h, 9 h, and 20 h in Studies IV and V.
5.6.3. Assessment of side-effects and
satisfaction
The incidence of nausea, vomiting, pruritus, and
sedation was recorded in all the studies. In Studies
I, II, IV, and V urinary retention was also recorded
and was treated, as needed, with urinary
catheterization. Patients were asked in all the
studies to indicate their satisfaction with regard
to pain relief (0=no pain relief, 1=fair pain relief,
2=good pain relief, 3=excellent pain relief ).
Reported reasons for dissatisfaction were
recorded.
5.6.4. Assessment of psychomotor
recovery with DSST (III)
Psychomotor recovery was measured with the
Digit Symbol Substitution Test (DSST)
(Wechsler1958; Stone 1984) (Appendix 1), which
measures changes in sensory processing
performance and in subjects’ ability to concentrate,
although a motor component (hand and finger
movements) is also involved. This is a simple pen-
and-paper test shown to be sensitive to the effects
of drugs that influence cerebral function
(Hindmarch 1980; Stone 1984). Subjects were
presented with sheets of paper containing 200
randomized digits (1-9) arranged in 8 rows on
each page. During a period of 90 s, the subjects
were asked to replace the digit with a predetermined
symbol, indicated by a code at the top of each
page. The code was changed between tests to reduce
the learning effect. The score was the number of
symbols correctly produced by the subject. This
test was assessed preoperatively for baseline values
and twice after the operation, 3 h after the end of
anaesthesia, and on the first postoperative morning
at 9.00 hours.
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5.6.5. Blood sampling and laboratory
methods
In Study I, venous samples for the determination
of plasma concentrations of oxycodone and
morphine were drawn twice, just before the patient
left the recovery room and on the morning
following the operation. The plasma was separated
and stored at -20°C until analyzed. Plasma
oxycodone concentrations were determined in
duplicate by gas chromatography (Kalso et al.
1990). The lower assay limit of the method was 3
ng/ml and the daily coefficient of variation was
6.6% at a concentration of 17.7 ng/ml (n = 10).
The plasma concentrations of morphine and
morphine-6-glucuronide were assayed by use of
reversed-phase ion-pair high-performance liquid
chromatography (HPLC) (Svensson et al. 1982).
The lower limit of detection of morphine and
morphine-6-glucuronide was approximately 1 ng/
ml, and the coefficient of variation was less than
5% for both substances. Concentrations of
morphine-3-glucuronide were not reported in the
results, because this lacks any analgesic activity
(Pasternak et al. 1987).
In Study III, samples for arterial blood-gas
analyses were collected from a radial artery catheter
at least twice during the operation, and 30 min and
2 h after analgesic loading in the recovery room,
where each woman breathed 35% oxygen through
a Venturi mask.
5.7. STATISTICAL METHODS
Student´s t-test was used for comparison of
demographic parametric data. Comparison of
two groups with nonparametric values was done
with Chi-square analysis or Fisher´s exact test in
small sample sizes or the Mann-Whitney U-test.
The Kruskal-Wallis one-way analysis of variance
was used for comparison of VAS scores in several
groups (IV). Correlations between VAS and
plasma concentrations of morphine, morphine-
6-glucuronide, and oxycodone were tested with
simple regression analysis in Study I.
Statistical analyses were performed by
SigmaStat for Windows, version 2.0 (Jandel
Corporation, San Rafael, CA, USA). Parametric
values were expressed as mean ± standard
deviation (SD) and nonparametric values as
median (range).
In Study V, the number of patients needed was
determined by power analysis. With a chosen
power of 0.80 and at a significance level of 0.05,
the sample size was calculated to demonstrate a
22% difference in consumption of bupivacaine-
fentanyl solution for postoperative pain. The
values for standard deviation required for the
calculation were based on our earlier experiences
on the need for epidural solution. In all studies,
a P  value less than 0.05 was considered
statistically significant.
Figure 1. Modified Visual Analogue Scale (0-50 cm).
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6. RESULTS
6.1. DEMOGRAPHIC AND
ANAESTHESIA DATA OF THE
PATIENTS
In all these studies, groups were comparable
regarding age, weight, height, and gender (Table 3).
In Study I, one patient in the oxycodone group
was excluded from the study because of
malfunctioning of the PCA pump. In Study II, the
PCA treatment was discontinued in two patients
in the oxycodone group. In Study III, five women
in the tramadol group and two women in the
morphine group had to be reoperated upon during
the first postoperative 24 h. In Study IV, one patient
felt intense pain in his back when the epidural
infusion began and was excluded from the study.
In Study V, four patients were excluded due to
technical difficulties in epidural catheterization, and
one patient due to missing data.
The distribution of type of operations was
comparable between the treatment groups in
Studies I and II. In the other studies, operations of
all the patients were similar. Duration of anaesthesia
in Study III, duration of surgery in Studies I to III,
and loss of blood in Studies II and III were almost
identical. The total peroperative alfentanil dosage
in Study II and fentanyl dosage in Studies I and III
did not differ between the groups. The median of
maximum cephalad level of subarachnoid analgesia
was similar in the groups 60 min after induction of
spinal anaesthesia in Studies IV and V. Three patients
in both the F10 and the F5 group, and two patients
Table 3. Demographic data of the patients: means ± SD.
Gender Age Weight Height
(F/M) (yr) (kg) (cm)
Study I
Oxycodone 19/5 39±11 76±15 169±6
Morphine 20/5 44±11 78±12 166±8
Study II
Tramadol 18/9 30±10 66±12 169±9
Oxycodone 15/10 29±10 63±12 171±10
Study III
Tramadol 25/0 50±5 73±11 165±5
Morphine 28/0 51±6 68±8 165±5
Study IV
F10 5/14 30±8 78±15 173±10
F5 6/12 32±8 79±12 176±7
Saline 4/14 31±8 77±12 176±9
Study V
PCEA 21/5 71±11 70±9 165±10
EPI 20/3 74±8 70±10 163±8
F10 = bupivacaine 1 mg/ml + fentanyl 10 µg/ml, F5 = bupivacaine 1 mg/ml + fentanyl 5 µg/ml, PCEA = patient-
controlled epidural analgesia, EPI = continuous epidural infusion
Results
31
in the S group needed an additional bolus of
lidocaine 10 mg/ml with adrenaline through the
epidural catheter during the operation in Study IV.
Two patients in the PCEA group and one patient
in the EPI group were given an additional bolus of
lidocaine 10 mg/ml with adrenaline in Study V.
Need for sedation or i.v. analgesics during the
operation was identical between the groups in
Studies IV and V.
Need for ephedrine intra- and postoperatively
was similar in both groups in Study V. Seven patients
in both groups were given atropine for bradycardia
intra- and postoperatively in Study V.
6.2. POSTOPERATIVE PAIN RELIEF
(I-V)
6.2.1. Analgesic efficacy of oxycodone,
morphine, and tramadol (I-III)
Amounts of i.v. oxycodone and morphine of PCA
needed in the recovery room and on the ward were
similar (I). Need for oxycodone or morphine for
pain relief at different time intervals was equal in
milligrams in the two groups and within the surgical
subgroups, surgeries being a plastic reconstruction
of the breast or a major operation on the vertebral
column, such as lumbar laminectomy and spinal
fusion. The potency ratio of tramadol to oxycodone
was found to be approximately 8:1 (II), and the
potency ratio of tramadol to morphine between
8.5:1 (loading) and 11:1 (PCA). Analgesic
requirements of the different opioids in Studies I
to III are presented in Table 4.
In Studies I to III, no significant difference
appeared between the two analgesic groups in
median VAS scores for degree of pain at rest or
during activity (Table 5). VRS scores were similar
at rest and during activity in both groups in Studies
II and III.
In Studies I to III, median VAS scores at rest on
the ward were 3 to 15 (6-30%), which can be
considered adequate pain relief (Ready and Rawal
1996). The highest median VAS scores during
Study I were 26 (52%) in the morphine group and
19 (38%) in the oxycodone group. In Study II, the
corresponding numbers were 13 (26%) in the
tramadol and 15 (30%) in the oxycodone group,
and in Study III 22 (44%) in the tramadol and 21
(42%) in the morphine group.
6.2.2. Quality of analgesia and spread
of motor and sensory block (IV-V)
In Study IV, nine patients in the F10 group, seven
in the F5 group, but only one in the S group needed
no PCA morphine during the study (P<0.05).
Table 4. Analgesic consumption (mg) in Studies I-III: means (95% confidence interval for mean).
A B C D
Study I
Oxycodone — 16 (10;22) 13 (8;17) 35 (23;47)
Morphine — 16 (10;22) 12 (8;16) 27 (18;36)
Study II
Tramadol 38 (26;50) 39 (19;58) 42 (27;58) 81 (50;111)
Oxycodone 3 (2;4) 4 (2;6) 7 (4;9) 12 (6;17)
Study III
Tramadol 51 (34;69) 115 (69;162) 29 (12;45) 180 (96;264)
Morphine 6 (5;8) 8 (4;12) 2 (1;3) 20 (13;28)
A = during loading, B = in recovery room, C = in the evening, D = during the night
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Table 5. Median VAS scores in centimetres (0-50) in Studies I-III.
In recovery room That evening Next morning
Study I
Oxycodone R 18 (0-39) 15 (0-40) 13 (0-44)
Morphine R 14 (0-39) 10 (0-28) 9 (0-46)
Oxycodone A 20 (0-45) 24 (0-40) 26 (0-48)
Morphine A 19 (0-47) 16 (0-38) 13 (0-50)
Study II
Tramadol R 8 (0-28) 9 (0-26) 3 (0-29)
Oxycodone R 8 (0-30) 10 (0-28) 5 (0-27)
Tramadol A 11 (0-38) 13 (0-39) 8 (0-40)
Oxycodone A 15 (0-30) 15 (0-31) 12 (0-33)
Study III
Tramadol R 12 (0-32) 10 (0-30) 12 (0-21)
Morphine R 16 (0-40) 11 (0-27) 9 (0-25)
Tramadol A — — 14 (0-40)
Morphine A — — 20 (0-37)
R = at rest, A = during activity
Both epidural infusions (F10, F5) provided better
analgesia than did epidural saline plus i.v. PCA
(S) (P<0.05), when VAS scores were compared
(Table 6). Medians of the maximum cephalad level
of the block during the postoperative period varied
from L1 to L3 in the F5 and F10 groups, but in
the S group 16/18 had no sensory block 20 h after
starting the epidural infusion (Table 7). Three
patients in the F10 group, three in the F5 group
and ten patients in the S group had complete
recovery of the motor block 20 h after starting
the epidural infusion in Study IV. Those three
patients in the F10 group needed 0 to 12 mg of
morphine, those three in the F5 group needed 0
to 12 mg of morphine, but those ten in the S
group needed 21 mg to 117 mg of morphine
during the study period.
In Study V, pain scores evaluated by VAS and
VRS in the PCEA and EPI groups were similar
(Table 6). In the PCEA group, 9/26 patients and
11/23 in the EPI group had no demonstrable motor
block at the end of the study period, whereas ten
patients in the PCEA group and six in the EPI group
had a motor block score 2. The spread of sensory
analgesia in both groups was similar in Study V
(Table 7).
6.2.3. Rescue medication
In Study I, six patients in the oxycodone group
and one in the morphine group demanded the
predetermined six bolus doses per hour. In Study
II, one patient in the tramadol group made
demands for more than the 4-h limit of the
PCA pump. In Studies II to IV, i.v. PCA opioids
provided sufficient analgesia, and no rescue
medication was needed. In Study V, 73% of the
patients in the PCEA group and 74% patients
in the EPI group needed additional oxycodone
doses for analgesia during the study. In the
PCEA group, eight patients and eleven patients
in the EPI group needed more than two
oxycodone doses, but the mean number of
oxycodone doses per patient in both groups was
two in Study V.
6.3. SIDE-EFFECTS
Incidence of nausea was slightly greater in the
tramadol than in the oxycodone or morphine groups
in Studies II and III (Table 8). Study I revealed no
statistically significant difference between the groups
in the number of patients who were nauseated or
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Table 6. Median VAS scores in centimetres (0-50) in Studies IV-V.
In recovery room That evening Next morning
Study IV
F10 R 0 (0-22) 0 (0-8) 0 (0-22)
F5 R 0 (0-16) 0 (0-15) 0 (0-26)
Saline R 0 (0-19) 10 (0-26) 10 (0-19)
F10 A 0 (0-28) 0 (0-20) 0 (0-32)
F5 A 0 (0-33) 0 (0-30) 0 (0-35)
Saline A 0 (0-20) 19 (1-50) 20 (0-38)
Study V
PCEA R 14 (0-47) 20 (1-35) 14 (0-34)
EPI R 10 (0-37) 10 (0-34) 12 (0-30)
PCEA A 18 (0-47) 25 (1-47) 30 (0-50)
EPI A 14 (0-40) 20 (0-40) 23 (0-40)
F10 = bupivacaine 1 mg/ml + fentanyl 10 µg/ml, F5 = bupivacaine 1 mg/ml + fentanyl 5 µg/ml, PCEA = patient-
controlled epidural analgesia, EPI = continuous epidural infusion,
R = at rest, A = during activity
Table 7. Maximum cephalad level of block (medians) in Studies IV-V.
In recovery room That evening Next morning
Study IV
F10 L1 L2 L2
F5 L1 L2 L3
Saline L2 norm* norm*
Study V
PCEA L2 L4 L5
EPI L2 norm* norm*
F10 = bupivacaine 1 mg/ml + fentanyl 10 µg/ml, F5 = bupivacaine 1 mg/ml + fentanyl 5 µg/ml, PCEA = patient-
controlled epidural analgesia, EPI = continuous epidural infusion,
* normal skin sensation
vomited. In Study II, during the analgesic loading
or immediately after it, four patients in the tramadol
but none in the oxycodone group needed droperidol
for nausea. However, in Study III during loading
48% of women in the tramadol and 4% of women
in the morphine group suffered from nausea and
were given droperidol (P < 0.05). No difference
appeared in incidence of urinary retention in Studies
I, II, IV, and V (Table 8).
No evidence of respiratory depression or
excessive sedation existed in Studies I, II, IV, and V.
In Study III during loading, three patients in the
morphine group had low PaO
2
 values but had no
need for respiratory support. In Study I, one patient
in the morphine group developed septic fever on
the day after the operation, and in Study III, one
woman caught pneumonia on the second day after
the operation. In Studies IV and V, no infection of
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Table 8. Patients (%) with side-effects and complaints about the analgesic therapy during Studies I-V.
Nausea and vomiting Urinary retention Pruritus
Study I
Oxycodone 18 (75) 3 (13) 4 (17)
Morphine 17 (68) 3 (12) 6 (24)
Study II
Tramadol 18 (67) 1 (4) 3 (11)
Oxycodone 11 (44) 1 (4) 1 (4)
Study III
Tramadol 14 (78) — 5 (28)
Morphine 17 (68) — 10 (40)
Study IV
F10 11 (58) 8 (42) 6 (32)
F5 6 (33) 5 (28) 3 (17)
Saline 4 (22) 3 (17) 0 (0)
Study V
PCEA 13 (50) 8 (31) 0 (0)
EPI 14 (61) 11 (48) 1 (4)
F10 = bupivacaine 1 mg/ml + fentanyl 10 µg/ml, F5 = bupivacaine 1 mg/ml + fentanyl 5 µg/ml, PCEA = patient-
controlled epidural analgesia, EPI = continuous epidural infusion
epidural catheterization was discovered.
In Study V, four patients were unable to operate
the apparatus correctly. In addition, one patient in
the PCEA group confused the button of PCEA
apparatus with the call bell.
6.4.PSYCHOMOTOR RECOVERY
WITH DSST AND SEDATION (III)
The DSST after the operation could be adequately
performed at the three planned times in 14/18
patients in the tramadol and 17/25 in the morphine
group, with no difference in DSST between groups.
In the morphine group, four patients who could
not focus their vision and four other patients who
were deeply sedated could not perform the DSST
and in the tramadol group, four deeply sedated
patients were unable to perform the DSST test.
6.5. PLASMA CONCENTRATIONS
OF OPIOIDS (I)
In the recovery room, the mean plasma level
of morphine was 32 ng/ml (range 0-235 ng/
ml), and of morphine-6-glucuronide was 27
ng/ml (range 0-82 ng/ml). At the end of the
study, the mean morphine concentration was
22 ng/ml (<1-102 ng/ml), and the mean
morphine-6-glucuronide concentration 27 ng/
ml (range <1-106 ng/ml). In the recovery
room, the mean oxycodone concentration was
38 ng/ml (range 0-100 ng/ml) and at 24 h 38
ng/ml (range <3-98 ng/ml).
No correlation between VAS scores and
plasma concentrations of opioids and their
metabolites could be found.
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6.6. PATIENT SATISFACTION
 In Study I were three dissatisfied patients: two in
the morphine and one in the oxycodone group. In
Study II, all patients, except one in the oxycodone
group, were satisfied with their pain therapy. In
Study III, in the tramadol group five women among
those twelve patients who suffered nausea during
loading and had received droperidol wanted to
discontinue PCA treatment on the ward later
because of PONV. Altogether in Study III, seven
patients in the tramadol and three in the morphine
group wanted to discontinue the use of PCA
method before the end of the study because of
prolonged PONV.
All patients, except one in each epidural group
in Study IV were satisfied with the pain therapy;
8% of the patients in the PCEA group and 0% of
patients in the EPI group was dissatisfied with the
pain relief in Study V. There were two patients in
each group who could not describe the quality of
their pain relief in Study V.
Results
36
7. DISCUSSION
7.1. THE RESEARCH
METHODOLOGY
All the studies were performed in a prospective,
randomized, and double-blind fashion with
standardized anaesthetic techniques used in all
cases. The intraoperative doses of analgesics in
Studies I to III, and the method of combined
spinal epidural anaesthesia in Studies IV to V, were
also standardized in order to compare the analgesic
efficacy of opioids and compare the different
analgesia methods. During the induction of
anaesthesia, during surgery, in the recovery room,
and on the ward, the patients were observed
according to clinical routine.
7.1.1. Measures of analgesia
The objective measurement of pain is quite difficult,
but it has been shown that of the various methods
for measuring pain, the visual analogue scale (VAS)
seems to be the most sensitive (Huskisson 1974;
Revill et al. 1976; Tigerstedt and Tammisto 1988).
A 50-cm scale was used in the recovery period for
its presumed greater accuracy compared to that of
a 10-cm scale (Tigerstedt et al. 1988b). For a better
visual display of VAS, a ruler 50 cm long and 10
cm broad was used, with an increasing red field
representing pain intensity. Such a large and
coloured ruler may offer additional reliability in
measurement of the intensity of pain in the
postoperative period when the psychomotor skills
of the patients are restricted because of drugs and
the strange environment.
The efficacy of analgesics can be estimated when
analgesic consumption by use of PCA is analyzed
in comparable groups of patients (Lehmann 1993,
1995). Equal pain relief by i.v. PCA with the various
different opioids investigated was achieved in
Studies I to III.
7.1.2. Measurements of plasma
concentrations of opioids
The methods of analysis of Study I, reversed-phase
ion-pair high-performance liquid chromatography
(HPLC) and gas chromatography, have been
considered to be valid and reliable (Navaratnam
and Fei 1984). Although the concentrations of
opioids and metabolites produced a large variation
in Study I, the results can, however, be considered
clinically relevant and may reflect the great
individual range in need for analgesics. The plasma
concentrations of those opioids that cause sufficient
analgesia have varied greatly (Graves et al. 1985;
Kalso et al. 1990; Eriksson-Mjöberg et al. 1997).
7.2. POSTOPERATIVE ANALGESIA
Opioids were administered in Studies I to IV by
i.v. PCA at dosages adjusted for weight, but the
efficacy of a morphine dose is reported to be
unrelated to factors other than age (Macintyre and
Jarvis 1995). These investigators found that at least
the loading dose should be adjusted by age and
that during the first 24 hours after surgery, age
was the best predictor of morphine requirements.
Older patients required considerably less opioid
than did young patients. However, in that
investigation age was shown to have only a limited
influence on morphine requirements between ages
20 and 60, and almost all the patients in the present
Studies I to IV fell within this range.
Providing adequate preoperative information
about PCA results in diminished anxiety for
patients and a reduction in the amount of pain
that patients experience (Jones 1988; Chumbley et
al. 1998). In the present studies, all the patients
were preoperatively informed about the PCA
treatment and were instructed in the use of a PCA
pump.
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It was interesting to note that some patients
considered some pain to be an acceptable part
of postoperative care. Higher doses of opioids
do cause more side-effects: higher doses of
morphine than in the present studies have caused
sedation during recovery-room observation
(Kalso et al. 1991). On the other hand, some
patients obtain complete analgesia, whereas
others do not. This has been reported also in
other studies (Purdie et al. 1992). Many other
investigators have also found that patients will
remain in mild or even moderate pain without
making the maximum number of demands for
PCA available to them (Owen 1989a, 1990,
1995; Lehmann 1993, 1995; Doyle et al. 1994;
Taylor et al. 1996). The VAS scores during
movement were the highest, probably because
the patients appeared willing to tolerate more
pain temporarily or because they did not realize
that they would need more opioids before an
unexpected painful movement.
Psychological factors and the occurrence of side-
effects have been shown to have some predictive
value for MEC and the requirements of the
maintenance dose (Gourlay et al. 1988). In Study
I, the mean concentrations of morphine were
clearly above one reported MEC, 16 ng/ml
(Dahlström et al. 1982). A similar range of plasma
concentrations of morphine was discovered earlier
during i.v. morphine dosing (Murphy and Hug
1981). In Study I, VAS scores of pain were low at
the time that concentrations of morphine were
measured, the opioid levels can possibly be
regarded as indicators of the success of the analgesic
therapy. On the other hand, the oxycodone plasma
levels (I) corresponded to those seen previously
after i.m. administration of routinely used
oxycodone doses (Pöyhiä et al. 1992b). This
indicates that patients controlled their use of the
PCA system. There occurred no accumulation of
the opioids in Study I.
The earlier reported equianalgesic dose ratio, 2:3,
between i.v. oxycodone and i.v. morphine (Kalso et
al. 1991), could not be confirmed in Study I. In
the study by Kalso and co-workers, patients were
followed for only two hours in the recovery room,
and opioids were given by nurses. These patients
had undergone major abdominal surgery, after
which, the major component of the immediate
postoperative pain is typically visceral pain. In animal
studies, it has been suggested that κ-opioid agonists
produce visceral analgesia (Schmauss and Yaksh 1984;
Burton and Gebhart 1998; Simonin et al. 1998).
Because the nociceptive effects of oxycodone are
mediated by κ-receptors (Ross and Smith 1997), in
the study by Kalso and co-workers, oxycodone
provided postoperative analgesia after abdominal
surgery at smaller doses than for morphine (Kalso et
al. 1991). In Study I, also during the recovery period,
were mean amounts of opioids similar.
The potency ratio of tramadol to oxycodone was
approximately 8:1, and of tramadol to morphine was
between 8.5:1 (loading) and 11:1 (PCA). These fell
within the expected ratio range 6:1 to 12:1, which
was based on comparisons of tramadol with
morphine (Lehmann et al. 1990; Stamer et al. 1997).
 Even though rather many patients in Study IV
experienced complete recovery from the sensory and
motor block at 20 hours after start of the epidural
infusion, their pain relief was adequate. Because
PCEA allows patients to tailor the block to their
own requirements, some patients used very little
bupivacaine, whilst others used more bupivacaine
to achieve a good block (Purdie 1992). It appears
that patients try to obtain as good analgesia as
possible without unpleasant side-effects.
In Study V, bupivacaine-fentanyl consumption
during the 20 hours was less in the PCEA group
than in the EPI group. Similarly, a significant dose-
sparing effect has been found to be associated with
the use of demand-dose PCEA as compared with
standard continuous epidural infusion for analgesia
during labour and delivery (Ferrante et al. 1991,
1995) and after abdominal surgery (Boudreault et
al. 1991). In those studies, the reductions in analgesic
requirement were not associated with a reduction
in the cephalad extension of sensory blockade, in
degree of motor block or in pain scores. In those
studies, epidural fentanyl was not administered alone
but with bupivacaine, and the combination was
proposed to result in a greater degree of analgesia
while reducing side-effects (Fischer et al. 1988;
Breivik et al. 1995; Niemi and Breivik 2001). For
certain patients, a continuous epidural infusion may
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be the most practical way to accomplish adequate
postoperative analgesia. Modern pharmacological
means for the reinforcement of the epidural analgesic
effect include the addition of such drugs as
adrenaline (Breivik et al. 1995; Niemi and Breivik
1998) or clonidine (Eisenach et al. 1996; Paech et
al. 1997, 2000; Curatolo et al. 2000) to local
anaesthetic or opioid solutions.
The role of nonsteroidal anti-inflammatory drugs
(NSAIDs) in reducing the need for opioids has been
verified in several studies, and the concomitant use
of NSAIDs with opioids has been recommended
(Kostamovaara et al. 1996; Gillies et al. 1987). We
thus used NSAIDs and paracetamol in Studies II
to V. In Study III, only a small amount of
paracetamol was used, because larger doses of
paracetamol, as well as NSAIDs, might have caused
reversible platelet dysfunction and produced
disturbances in haemostasis (Niemi et al. 2000).
7.3. SIDE-EFFECTS
There seems to be no clear advantage in using one
opioid over the others, when each produces a similar
incidence of postoperative nausea and vomiting
(Kalso et al. 1991; Stanley et al. 1996). In accordance
with earlier studies (Vickers and Paravicini 1995;
Ng et al. 1998; Pang et al.1999), i.v. tramadol PCA
was associated with a disturbingly high incidence
of nausea and vomiting also in the present studies
(II, III).
Opioid-related side-effects, especially nausea and
vomiting, remain the most harmful problems in
pain management with PCA. Although in all the
present studies, PCA proved to be an effective
method in postoperative pain treatment, it was,
in fact, depressing to realize that PONV were such
common side-effects with the use of PCA or
PCEA.
For this, several potential explanations exist,
including increased use of the opioid and lack of
prophylactic antiemetic medication (Tigerstedt et
al. 1988a; Sharma and Davies 1993; Tramèr and
Walder 1999). In some cases, nurses may be
reluctant to administer special antiemetic
medication (Semple et al. 1992), and patients may
be unable to request antiemetic medication.
Side-effects such as PONV were obviously
important and troublesome complications of PCA
in the present studies. In future, therefore, much
more effort has to be put into reducing PONV
incidence. It is important to treat such side-effects
either prophylactically or immediately post-
operatively once the symptoms appear (Korttila
et al. 1985; Rowbotham 1992b; Lamond et al.
1998). Tigerstedt and her colleagues found that
for reducing nausea droperidol at the end of
surgery was effective (Tigerstedt et al. 1988a).
According to a systematic review by Tramèr and
Walder (1999),  droperidol was the best
documented drug, and its antiemetic efficacy was
clinically relevant as a prophylactic antiemetic.
The explanation for the relatively high incidence
of PONV, at least in study III, may be related to
the fact that all the patients were women, who are
more likely than men to experience nausea and
vomiting (Cohen et al. 1994; Larsson and Lundberg
1995).
In fact, one way to avoid these adverse effects
and to provide superior pain relief is to use opioid-
sparing strategies that reduce opioid requirements
(Kehlet and Dahl 1993; Etches et al. 1999). For
this purpose, the most commonly used
supplemental analgesic drugs are NSAIDs and
paracetamol. For instance, following total hip or
knee replacement, i.v. ketorolac has reduced i.v.
morphine requirements by PCA up to 44%, and
improved analgesia, as well as being associated
with reduced incidence of PONV compared with
that with placebo (Etches et al. 1995).
Because of these unpleasant opioid-related side-
effects, patients may refuse to continue PCA
treatment. As we know, postoperative nausea is a
very complex symptom with many factors other
than opioids contributing to its aetiology, and
patients respond individually to PCA opioids.
Study IV, with epidural fentanyl infusion
compared to PCA morphine alone, showed a clear
tendency towards greater number of various
systemic opioid side-effects without any respiratory
depression with the higher concentration of
epidurally administered fentanyl. In general,
lipophilic opioids in low concentrations rarely
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cause respiratory depression, but nausea, vomiting,
and pruritus are relatively common side-effects
(Rawal 1996).
Neither the best antiemetic prophylaxis nor the
best rescue medication for PCA-related PONV has
been established (Woodhouse and Mather 1997;
Tramèr and Walder 1999).
Tramadol has been found to be minimally
sedative (Hopkins et al. 1998). However, Study III
showed no difference in performance of the DSST
test between the tramadol and morphine groups.
Sedation or blurred vision prevented performance
of the DSST test in 22% and 32% of the tramadol
and morphine patients, respectively (NS), some of
them because of marked sedation probably mainly
due to the analgesic.
In the present studies, respiratory depression and
sedation caused no problems, probably because most
of the patients did not titrate themselves totally
pain-free. Postoperatively, because patients remained
on the ward, where they were not monitored with
pulse oximetry, in some cases transient hypoxaemia
may have occurred undetected.
7.4. SAFETY
An advantage with PCA is avoidance of wide
swings in plasma analgesic concentration compared
with the situation in i.m. dosing, although with
continuous epidural infusion a steady state in
concentration of local anaesthetics and opioids
would be better maintained. PCA may be a
disadvantage during the night-time, when plasma
opioid concentrations decrease below presumed
analgesic levels, causing the patient to awaken in
pain.
PCEA seemed to be a safe and useful method
also among elderly knee arthroplasty patients (V).
The number of epidural catheter-related problems
in Study V was 4/54 (7%), lower than in the study
by Andersen et al. (2000), where 17% of the
patients after transabdominal surgery had the
epidural catheter reinserted due to misplacement
or malfunction of the catheter.
With proper epidural dosing, the sensory block
height remained at low dermatomal levels (IV-V).
According to Purdie and co-workers (1992), the
upper level of the epidural block in obstetric patients
during PCEA with 0.125% bupivacaine was
observed to be above T7 in seven of 75 mothers;
so careful regular monitoring of the upper level of
the epidural block is required.
Some of the elderly patients were shown to have
difficulties in conceptualizing the working principle
of the PCEA apparatus. There exists a high
incidence of postoperative confusion even in elderly
non-demented patients following major surgery,
regardless of the route of analgesic administration
(Williams-Russo et al. 1992).
In one study, postoperative fever was reduced to
a greater degree in the PCA group than in the i.m.
group, and a significant reduction was also noted
in the postoperative pulmonary complication rate,
as evidenced by radiographic findings in the PCA
group (Lange et al. 1988). These investigators
speculate that the additional benefit from using
PCA is that the patient assumes control of his or
her well-being, and this provides a spontaneous
mechanism of self-care (Lange et al. 1988).
Several published and anecdotal reports of pain
management with opioids and concomitant use of
benzodiazepines or barbiturates describe patients
who ceased breathing (Bailey et al. 1990; Baxter
1994; Avramov et al. 1996). For this reason,
concurrent administration of other centrally acting
drugs such as sedatives and hypnotics should be
avoided.
Respiratory rate is a simple parametre and easy
to monitor. Although commonly used, as in the
present studies, respiratory rate alone is, however, a
relatively poor indicator of respiratory depression
(Ready et al. 1988; Whipple et al. 1994; Leino et
al. 1999). More sensitive methods of monitoring
analgesic drug-induced respiratory effects are
continuous pulse oximetry, intermittent blood gas
analyses, and monitoring of apnoea and CO
2
response (Moon and Camporesi 2000), although
these methods are often rather impractical on the
ward. The most important method is to monitor
the patients’ level of consciousness.
The risks of human error and complications were
minimized during the present studies, because a
strict, standardized means of monitoring of pain
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and pain therapy was followed, and side-effects of
pain therapy were monitored frequently. The
anaesthetist’s having checked the patient and the
PCA pump regularly may be one reason for
avoidance of such problems as program errors.
7.5. PATIENT SATISFACTION
Patients’ general satisfaction in all the studies
regarding the postoperative analgesia was good. The
adequacy of pain relief and patients’ feeling safe may
have caused this positive attitude (Chumbley et al.
1999). In addition, frequent assessment by the staff
might have a favourable impact on patients’
satisfaction (Jamison et al. 1997). Dissatisfaction
with i.v. PCA has been shown to be highly
correlated with pain intensity, patients’
perceptions of support, their expectations of
recovery, and their anxiety (Jamison et al. 1993).
On the other hand, positive results obtained may
be the consequence of patients’ reluctance to
criticize their treatment and the fact that the
immediate surgical outcome happened to be
good. It has been shown that 5 to 20% of patients
complained strongly about lack of pain relief, and
PCA should be considered for those patients with
the most resistant pain (Tammisto 1978; Tammisto
and Tigerstedt 1982).
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8. CONCLUSIONS
On the basis of these studies, the following
conclusions can be drawn:
1. The analgesic efficacy of oxycodone and
morphine in i.v. patient-controlled analgesia after
plastic reconstruction of the breast and major
surgery on the vertebral column was similar. The
potency ratio of tramadol to oxycodone was found
to be approximately 8:1, and the potency ratio of
tramadol to morphine between 8.5:1 and 11:1. No
correlation existed between the analgesia scores and
plasma concentrations of opioids and their main
metabolites. Analgesia was similar with oxycodone,
morphine or tramadol by PCA. No difference
appeared as to side-effects except for nausea and
vomiting. Tramadol was shown to be associated
with a disturbingly high incidence of nausea and
vomiting both after maxillofacial surgery and after
microvascular breast reconstruction, probably in
part, because most of the former and all of the latter
patients were women.
2. Epidural infusion of fentanyl (1 µg/kg/h or
0.5 µg/kg/h) and (bupivacaine 0.1 mg/kg/h)
provided better pain relief but led to more side-
effects than was the case with i.v. morphine PCA
after knee ligament surgery. A tendency was seen
towards more side-effects with the higher
concentration of epidurally administered fentanyl
(1 µg/kg/h).
3. Bupivacaine-fentanyl patient-controlled
epidural analgesia after total knee arthroplasty
provided postoperative analgesia similar to that of
continuous bupivacaine-fentanyl infusion with
significantly (40%) smaller doses of epidural
infusion.
4. Carefully and correctly applied, PCA and
PCEA are safe and effective. In addition, PCEA
proved to be a safe and useful method among elderly
patients. The risk for clinically significant
postoperative respiratory depression appears to be
very low. Almost all patients were satisfied with
their pain therapy provided by i.v. PCA with
morphine and oxycodone, and also by epidural
infusions with bupivacaine-fentanyl solutions.
However, women’s satisfaction with i.v. PCA with
tramadol was poorer, the major reason for which
was the disturbingly high incidence of PONV.
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9. CLINICAL IMPLICATIONS
Patient-controlled analgesia (PCA) provides good
postoperative analgesia, but as is the case also with
i.m. opioids, it is associated with a high incidence
of postoperative nausea and vomiting. Major
improvements in postoperative pain therapy are i.v.
opioid PCA as well as continuous epidural infusions
of local anaesthetics and opioids. The two methods
are in most cases alternatives.
I.v. PCA is technically simple and easy to apply,
because postoperatively i.v. fluid infusions are usually
given as a routine. Epidural analgesia is nowadays a
common and elegant technique in postoperative pain
treatment. PCEA is not a routine method, however,
and although similar in principle to i.v. PCA, it
also involves the problems and risks of epidural
puncture and catheterization.
Because the use of PCA is not without side-
effects and risks, frequent general observation by
nurses on the ward is thus important. In addition,
sometimes during treatment it may be necessary to
alter the PCA program, to change the amount of
the bolus dose or duration of the lockout interval.
In some cases, it may also be more useful to change
the i.v. PCA opioid to another.
Clinical implications
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ORIGINAL PUBLICATIONS (I-V)
Errata
Publication I, (Comparison of analgesic efficacy
of oxycodone and morphine in postoperative
intravenous patient-controlled analgesia). Page 580,
the title of the twelfth reference should be:
Anesthesiology-based acute pain services: A
contemporary view. Also the name of the reference
book should be: Regional anesthesia and analgesia.
Publication II, (Efficacy and side effects of tramadol
versus oxycodone for patient-controlled analgesia
after maxillofacial surgery). Page 838, in Table 3,
no. of patients (%) with urinary catheterization in
the oxycodone group: 1 (5) should be 1 (4).
Publication IV, (Continuous epidural analgesia
with bupivacaine-fentanyl versus patient-controlled
analgesia with i.v. morphine for postoperative pain
relief after knee ligament surgery). Page 41, the title
of the fourteenth reference should be: A comparison
of the hydrochloride and carbon dioxide salts of
lidocaine and prilocaine in epidural analgesia.
Original publications
